var title_f5_40_5760="Anterior rhinoscopy";
var content_f5_40_5760=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior rhinoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 347px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFbAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WYnceT1pMn1NDfeP1pKAFyfU0ZPqaSigBcn1NGT6mkpyqXYKoJYnAAoAmsba4vruK2tEeWeVgqIvJJr7M+BfwesvCVlFrGtRrcazKoKhxkQg9gD3rnv2bvhMun2sfiXX4QbmQbreJx90epr6DlYk+3pXQ/3S5V8T38v+Caxh3CUb+1VWTB6VbU8VFIaytY2g7aFKZeDisa7UlznNbsgyprKu14I71Ej0cNKzMOZDyecViatGfIfg10VyMcVh638tsxOOlcU49j3KEm9DyTXE/wBLbPGeM1nNF8yqOnrWvqah7mQnn0qgybWyeMUn2M5+879yxHDyp444qvq52w4B7Vo26jysgjn1rK1okR49acUYtXZgIjMecnJ45qSKLzpwATgdeaWRiigZzn2rU0y3ygYjrzSbtqcsvelY3fDOmFpFZgcDmu/t7RVjAPB/GsvwzbYiU46+1dN5AwDWUUm9TZq2hlyWobIX86pNYkykFc10UcYAPy8+9CWuQWI5PNa2Dbc5S7sRzxWDe2vzYAP5V6BeWgIJxXLapbGNi2M0NEp3OWltyj4xxUkFvtfkcVoSwh8ECnwRgjAFC2OiNtxsMPPqB2q5FAMjAqa2gGMnp9KuxQ5IAB61LRrF21HWsG4Dj8K2LRAIl9R6VHZw4HIq6qbVwBStY6oe7q9y7bRjjHetPyAYg3fFU7EfuxnnFaq/6n2rWMHI4682mRQKdhGec1bgTdSW8XQ4+tXolC1uqZw1ahNaxbdprSwAMVVhTKcVZY4AzW8VY8qrLmYBeKkWPC5pqVOOUq722MJSaPPfit8PbHxroksbxKt6gJjkHUGviHxZ4dvvDWrS2V/G6MjEAnvX6OlSK83+L3w0s/GmjyvFEqagiko4HJPpS5UzW8a0eSW/R/o/0Pg/J9TRk+prS8Q6Nd6Dqs9hfxNHNExXDDGazKhqxxNNOzFyfU0ZPqaSikIXJ9TRk+ppKKAFyfU1JGTt6nrUVSR/d/GgBjfeP1pKVvvH60lABRRRQAV9A/s3/CdtevU8Qa7ARpsJzDGw/wBY3+FcL8Evh7P478UxRSKy6bbkPPJjjA7V94aXp9tpOnQ2VhEsVvCoVVUY4raP7tc3V7f5/wCRa0VyTasUaxRKFjUYAAwAKbtyamwDTSuOazQ1Ij24qGcACrDHINVZSSv0pmsLtlV25qlcDcelWn681Wmbap5qWehSVnoY9wvzn0Fc34jkC2rgnrxXTXRx61yniH5o9ornqKzPbw92jze9U+aw561BPHgqMfWtm7gHmBiM4qpcxDr6d6we+g5LXQghXCBCM+lZ2uoSyAk8VrW4BOT0/lWbrShUL4pxMp9zm9vm3gTqBiuv0+2yYkPUmuS0X5rotgE54rvdLjBnQnPalUXQ56au7s7TQ4dkajuK2gisc4rMtAUjUitqxCuyqcAE8mojsbuPViw2/O4+lTLAM1t6lpgt40eCQMpHY1mMpXHPNWk72Zyxqxqq8WZt7D8uMYrnNZtgYjgZrsrhN0Z9RWDqUH7ps+laNDicDakGWSFj0PFWII8EgjIFU2/d65t/hYHNbMZjErKxxlcjNT6HRFj4BjgitK1ixyapWyc5OM1qWy5KikzaOjuy3br0AFWXjxHjvUtxafY3QFw27nirEUYdSD+FK3c0U9OcWzXCjNasC5hPpWfGm01p23+q+taQblscmIlfUkgwFq8ihl4qnEvyitG1jOOeK3UbHm1pW1LNtHtQZqWReBUqL8gxSsOlaK55rneVyCMHFTp0pyIMU9Vqr2RnKVxSuRTSNoqSmv0qUzNM8V+Pfwvh8WaZJqWnRBdSiGTtH36+ML60msbuW2uUMcsZKspGK/TMYyQRkHqK+Z/2mPhgZM+I9EgH/TdEH61ry8yt1OmX72NvtL8V/mfLlFKQVJBGCO1JWJyhRRRQAVJH938ajqSP7v40AMb7x+tJSt94/WkoAKvaNptxq+p29hZxtJPO4RVUZ61Rr6m/ZW+HBjH/AAlOrQYPS1Vh/wCPVpTim7vZFRV9z2b4ReCbfwR4St7JEX7XIA9w47t6V21LRUzk5O7E3d3G96a5wKeRUE2e1CHFXZDI3OVqOU5U0u4buRSlgRSbOlKxmSk1RnyW68VpzDGSKpTrwTSbPRoyMi76H2rn9SiLKWxXQ3C1mXi/JgeucVhNHs4eVlocNqMJRRgd6oXkWYVPrXQamF83DAHuay7lYy5EbHb157VnysdXf8DHjXZwRis3xGu20OPTrW4Y/wB6WHIqhrcPmWUhx0FJbmM9UcnoMf7wE16Fo8O4rxXDaMgDYOMjvXeWTeVpl1OpIMcDuGHUEKTmpqO7MYbHY2gDIFPar0LKr4XqO1eR/wDCUasvwvjcXTJ4gWUwS3I5YKg81n/79bf++q6Y+IHi1S4tbC1vNRvTeSqsDypGI40RC5ViOEy4AB5LHqBRyWHTrxlo+v8AVj2Pw0kdy7+cdxVflUntVPWkFvqbRqPl6141aePNXh+HzS2Ud5c6pBpIurrUEdEa2Z2YI20j52wpJA6Ad66ifxfd/wBralahG1fUZNUlhs4WnSBUgjghdiZG4CgucdSS+Pp1crnHXoea58tfnv7rR2I+dmxWfqkY2EdOKdoGrWus6NbanZbhBcKThwNyMCQynHGQQRx6U3UXBRsVgdq96zj1PMNeBg1aKT/axWmcMFk9BVLxUu5wwHIPBqaylD26ccY5FTc6l3NO15CmtOEYcHNZMT7QCO1aUD7kB6UeZtFXeprM4kK85I9aswy7SOeKz4egOasMTgUnJt3ZtyXRsQjccnvWskey2z61k6a+9VPoK23cNCqit6b7Hk4ltSURsAywrYhX5R6VmwJjbWvEQsYFaxueXiZdiRM4okHNOjORSSdRWiOLqPX7tPXpUUXUipqTIkFIaWikSQSL1xUM8EV3ayW1wgeKRSrKe4q24yKiCndVp6GsZHw9+0B8OpfB3iN7q0jP9mXRLIQOFPpXklfox8RvCVp4x8M3OnXSAyFSYmxyrV+f/ivQrnw5rt1pt6hWSFyvI6iqmuZc6+YVFzLnXzMeiiisjIKkj+7+NR1JH938aAGN94/WkpW+8frSopd1VRlmOAPWgDu/g14Jm8beMLazCn7JGwkmfsFFffmmWNvpthBZ2cYjggQIigdAK8s/Zv8ABCeFvBcV5cRgX9+BI5I5C9hXrtbVfc/d9t/X/gFt2XKgooorEgDUMtTVDMOOOtNFR3K0mBk1VZsNj1qeUkdR0qozbj05oO2nEc5GPWqNyeDjpVrY3JqrcbtpA60HVSSuZNxy2Kzbvdzx09q12TALNWfdJw3FZTR7FCaTOO1hHPzD86xyrKMk8HtXS6pECjDHHU4rn3TcwA+tYptaHVVV9iHITG+q+oRg27Ac5FXJomO3PQcmmvFujJYdBQkc0l/kcXbptutgA612tpEZtPltw2DNC8eSPu7lIz+tctLb+XqJbHBNdXpu827iJxHIVIRyu4Kexx3+lRPfQ55FF/BTSW08aXwzLpSWABQ7VmCqjT4/2kRVx7VPe6Teafqc2qadeWy3puJnCzxsYzFIqAqcc7laMMD0PQ0aLqOp28uvXWt6tayado07wyrDYbGkURq+/O44xu6YPT3q34g1zTdOa4ivXnMsawkxxQl2bzs+WFA6ltpGKJNsmiqW8tNe/b5nOaboV8bGfS9M1e1QXlilleSzwsT8pYiSMA8EhiCD9a6+/wDBP2y7k1CL+y726+2TXCWupW5ktzHLFGhVgDncpiDBh7iuC0jWkGrXENwtxC32028TtCVRcqGSN27SHJ4/CvUtC1BgAkpJPQGphUknZ6HXVwNCvDnpfntY1dJtG0zRLSyeWOSSBNrNFCIkY9TtQcKPQVBevlcA1fky6n86y7tgWOO1W2YxioqyOQ8RJmN89cVl6PLmAAnJBxWxrm9lcYOK5/RiwaYYHB7UuWxtFfgbsEp814zjHvWlaOQrD8qyYxh1bGM+taVscmlc3iupo28rkAelaO4tCCOayolwxPar8B+XB5qW7m9jZ0x8LW1bPvwPesLTfumta1O0e9b05WPMxUVdm9a/6wZHFXZFweOlVtPXcoJq8wG4CuiJ89Vl74RDgUsnLCkyFNKDuatDDrcfGO9S01RinVLMm7sKKKKQgNMI5p9FAJjQK+df2pvh6L/T/wDhI9NizPCMThR1HrX0Waq6lZQ6lYT2lygaGZCjA+9aU58r12e5cJWeuzPzIPHBpK7f4u+EZfCHjG8sypEDOWiPqDXEVM48krMUouLswqSP7v41HUkf3fxqSRjfeP1r074AeCG8Y+NoBMhNjaHzZjjjjtXmWCXwBkk4Ar7i/Zp8Hf8ACNeBo7u5j23l/iRs9Qvat6K5b1H0/Pp/n8io9z1yGNIYUjiULGihVA7AU+iisNyQooooAKimPFSGoHbPFNFRWpVk54NQmMA8VcZRmoJMgcUWOuMuxCcAdaqyqJDirMh4ORzUMak5NUkdENNSlPGAMd6z54gUORWxdLtBJrMn5U88mpaVtTuoTbOU1QBVkI6VhQRhpMnua6DWVO0478msOJj5yjoCe1c7VmexLWKaNPULGP8As0OAA+M8Vz+NseD1Iya39TnYRImeMc1kMPMHTr7UOKirnOk0vwOd1aDAWRRyDVvTJgIgvf3qzdQ71ZSOBzWTYOVuChHIPSs2ZVI66eho/wBkXVzpXi+1Dwo+ryySW7FsgBoUQb/TlT+FV5tG1nU9WXUryzt7I+dp7eR9qWRlWDf5hyBjPzDaO4rbsJcNkngVae76kHp71DkzFUFNqxx91oWpXF9cWUsECafLqw1I3YnBYIpVgnl9dxZevQA13dmkaH5Rgk5rMimR5S2Ru+taloC+GGaydmd8fci7Pc3A/wC5ANZ20FmJNTfMy4Gcj0prKABkHIrdWOVu139xha9GotnYj3rhdBuBLqV1H2HTFdX42v1tdPkJYZx3rzzwTMX1OZ2P3hnFUo6CUre6dxjrz0q9ZZ3dDiqETBwcfSrlu4HAJBHpWR2xd1c2Y8dRzVqEYb2rIjn2xkk9Kv2k4cnB+lBtG5vaaQMite2+/wC1c9p8w8z610GmtvBJrSmcOLja7OjsXXywOlWgd7cVQtUI246GtGBNprrifNVrJtkWCH56VYiUgZp2wbqeVqjCU76Dh0oooqTIKKKKACiiigApKWigDxL9pzwMniDwo2q2seb2yGSQOStfFRBBIIwRxX6d31rHe2c1tOoaKVCjA9wRX57fFrwxJ4U8bahYspERkLRn1BrZ+/Tv1X5Gj96N+xxlSR/d/Go6kj+7+NYmZ1fwt8OyeJ/HWm6eilkMoZ/90Gv0PtIEtbWKCIARxIEUD0AxXzJ+x74YBGo+IZk5DGGIkfnX1BXRV9yEafzfz2/D8xvYKKKK5xBRRRQAGoWHtU1NNNMadipJkdKhYnFXZBxVOUYqkdFN3K7ZJwaFWlfp70IcdadjpvoZutSMse1OtZEbOwAbmuku0V4zlRntWOltscluhrObaPQw1WKp2MTU4PMDccYrmUj2THcO/eu7uolCE9a5a/g23AKjisJXTuz1KNTmj6Fa+jd7dWrOjVgpY/WuglkVrcR4HIrOtLczy7AMDvTle1yb8qa7fmUSu9GLD3rmdSj+z3AcDGa62WLbdGLtmsTXYASeB8vNQ0rGb10XoJZyfugQTk9anTe6sCcVl6VMC+w9BW0WVnrnabEpcr09EV0t2jdX/nXS6e/7sA/erCDgvyeM1ftrtVlUd/ShRa+RpOrzLTpojoIjtGTVO8uAiyOeFFQyX53YAwPauF+InipdOsmjRh5rcBRW8Y9Dlbs9dkcv471n7dffZo2BReWqh4VnMd9nHykYrmLe4eQtJIdzscmuy8OWZjtPOcH5ulXUfJEmi/aSVjq7W6yxxggj8qsJcESbgR09a5i1uvLuWUtkBuPxrXkbOGU5BrnPUpq75TchuxLDuHKng0ulXjJN5bcgZwaxdLnI3IegPFX1GJ8jjvUt66HVFX0R1tnc7JlPqa7DSH3xnB5zXnUUzfIQeK7LQLggjng4q4S1sc+Npc1O6O6sT8mG6gVbhJZjjpVC1bcgbPar9qwrtjsfHVlZtlqlpueaUUzjFooooAKKKKACiiigAooooAK+df2tfB5vdHg1+1jzJbnbLgdq+iqxfGWkx654Y1HT5VDCaFgM+uOK1oySlZ7PQ0pvW3fQ/NapI/u/jVrWrJtO1a7s3GGhlZPyNVY/u/jWbVnZmbVtD9D/AITeH4vDXgTTLGKMIxjEjj/abmuwpsSCONEUYVQAB7U6rqz9pNy7gwooorMAooooAKaadTGzimhoY79RVWboc1KTzzTJF3Dir2N4KxTA3P16VOAMc0wpsapdp25oN5MqzAnp0qnMAeK0JBgHNVpFB7dqGbU5GbcKmwjiufmUCdgRkV0Nyg2muduwyuWrnq2Suz2cGUL6MJmSPoe3pVO3uRBcBzxvGK1HTzbZgR1rJ1OEhEKDOOKzTsdM1b5fmWTAst2HVsl6i8Q6KI7PzlyeORT7OTd5RU4IPP0rc8R/Noh24561SjzbHLOTptJenzPH5SLGXcxwG6GrUWojbw2fxpuvWxuLVlX7y85rkI7k+aIiWDCsnHl07BKy17HcrfKYwARzUkF8E3H+LtXKRXqDAJxn9am1DU4oYss+BjINTZ3sPmUfl+Zp614rj063eRj8wHy+5rxzU9RuNa1Fp5mJycgDsKd4m1J9QujtJ8teBUOnx4jGPvMenfNdEVyrU82rU9pP2cdupq6fbmSaOKMZYkZr0QDy7NY1A4WuY0K0Fm/myjMrcAeldCshYAYrnnO+x6WHp8kebqyhPH++3YxWxC4eNeRVC5X7pPfvViyJ3YJBrN7HfBW0RfsV23eTjBrUficA56c1lR5E4IxitYNuZDkmoemjOpPl0RpWYzGQe1dNoDElRXMWjAuB07V0mgPtnAGODThuKtG9JnodipEA+ladsMrxVGxO63XHpWlaL+7r0Y6Hw2IlqyYHilBoxSYO4GrOMdRRRSEFFFFABRRRQAUUUUAFIQCCD0NLRQB8GftEeH20L4jX2FIiuWMqHHHNeZx/d/GvqX9sbRN1rperonKkxO38q+Wo/u/jW1bWXN3NKvxX76n6f0hpaKxMwFFFFABRRRnFABmmM1O60jAU0NEDjPNN6DmnuwFMJ96o2QwqGbNPOMUgwaZIcdBTK3diGU9qqvz3qdmJ6iq79880M6qasUrhS3FYepxheK35GIzWTqEZwWNYVNj1cLLlkjOtYyVIxkEVZNtFcWbjaN2KfZlRE2evvSwvsjk+lRBaanTWk2210OMSRoLp1Y9+BW3fXTvoJfjI4rJuFWW8IXru71vG2jk01lB5Ip3cGKaslfp+Zw0IScyjbyRXC6tYLBqj7CF3c5NehiExXeEAAJx0rhviUj215DLGSHPB96i12Z1fcXp+ZkT7lVg6bh2K+lctrlywTau7BOME9K021OYxbNvHTJFc7qsjNIMkjvmqjFo4KtRqNjNl+ZlHUGur0bTzD5c8hy3ZPT3rl48LIrHA5zXW6XerOu7JJ7Y6UqrdtCcDBSnqbKsN2TnNaETgKCDnPFZKsSwzkir1u5Z0HPJ5rmZ70VfXoi/cdQRyMUtucGlZdzg++KQ/I+OnPFRfqbQXKuZl6FvnGeD61uWyYUFuR71gRcOh45rqY03Wqnk8UmzograsfCAZDjA71u6G3+kiueizHJwecVu6KR9pXn60J6jqO8Wj1HR/mtRzWtanCEe9YegSfuivcVuQn5z6V6UHdHwmLVpyRNRRRVHEFFFFABRRRQAUUUUAFFFFABRRRQB5b+0fpJ1T4Y3+1cvBiQcdK+E4/u/jX6R+NrL+0fCmqWuMmS3cAe+K/OS8hNte3MLDBjlZfyNay1pp9jWWtOL9V+v6n6bUV8tfCn9oR0lj07xXukjPyrcdx9fWvpfR9VstYsku9OuI54HGQymplBpXWqFKm0uZaovUhoPFNJqCEOFMmGRxTlNKcYp7AtGRoSF5pplBOBUlRMBnpQi1ZshkGeajXrzUkhPpUIPzUzeOxOOnApjEntUqkY6VFJyeDTQluQye9V2XNTyA5qOXhTUtnRBlV1LNiqGoxkrgCrqtsPOaLhQ67gKzfmdcJOEkzlrhjGwUcc1asGV3eNzjcOBTprQyXOD36ZpJbN4nyTtasotweux6spwlHlvqc5e2b22ouxPyk8ZrT024DW7A4HapZAJ7lBIB6Ump2QiTNscZ6ins7ibSSjL+mc9MFhuGlOCobFcL8TJormOHYoZ17j0rtdU+VXjfgsOtcdqmkNMIgGyz/KB1qeZLcqrS0s+mvzPMpGxyMADPFc9dSGW5HPSvRPEfhlvsUxhzHeQjLRjo49RXnSKUkO7gg8561pF31PDrxcXysivCFIC4561p6LPtIUA4OMgcVkXXXpz61Pojk3SIO5okrozoVHGrddTvYACmRjB9a0NNBe5XPAxVVAP3aj0xxV+FNtwvDCuFvofT0VzWj0NGfCMAucZolTkYBH4U8rvMYA4yK1WtVNqzADNRc6uXmd3sjLjztAxyO9dVpx32ijtiuXVDvCkZ9cdq6fRtohYN1HSle70LjeY8IzTHPatvQEJvE9KzkTEh9COK1NBbbfoD61cN1c0rJKnK3Y9E0YBJD61u88EdKxNNGHz2NbQAEQIPNelE+Dxes7k6nIzS01eVBp1UcDCiiigAooooAKKKKACiiigAooooAZOgkhkQ9GUivzo+Iln9h8b61BjAW5bH51+jVfC/7QGlCH4pasIlwrFX49TWsFzQa9DWKvTfqjyU/eP1r0b4W/EvV/CWpRRpcu1oxAKMcj8a85b7x+tXtI0y71S8jgsoXkdmAyoziohJxehNOcoO8T9F/CeuxeIdDtr+HgSKCQOxrXDEiuJ+EGi3Oi+DbWC9VklI3bW6iu0H6UTa5nY1qqKm+Ukj5qQ9KYtOFSYMbUcpqeq0wOaaKhqyI5xUa/Q1IWA4p3BXimb3sNIwtQSKSMg1MWG3FRg89KL6FR0IQDjmmSEgEGrBwCM0yfbsNZvY1UtTPkXuaXG5MClcjOO3enoBkYFRc6W9Ck8YEqnuKNRUv93GQM1bnAB461SmZklO8cEU9Fua05OTT7GGyrkyDh17VOZFnhyDkipDYvLHI4qhp7lZnikGBjAFRs7S9Wen7souS6GT4ghElvI+3BQcVxyXD3d1EkHDRcmuq1y7wGhB3fzrldL2pNLJggHpWc1rp1NHdQtL1ZDrO6e/zuAKrnPr7V494uSNdabyht3dVr0nVpn/ALTOGIT+tcL4yVFuhK2D8uAe+aqL/E8rE+9HXdnH6iNhBxxjFXvC0Rl1JOCdvJ29azrqTzME4wK6D4fwvNqbiME/Lg4FaTdos86jZ1kd/otkJJtzHhehPY1oXcSrcqR/COtaVtaLZ2qjgEnJqsIjLdEsMr2FeW31PqaCekVux1naF2DHoO1b9nEr25z16VRjXywc9/StKxdVGDxSUrOx6E4tpU4mTdwLBcH5eTzU9lIY+nfpmn6mytMAMfhTVA+U4yRwKL2NI2pqxtRnEUb9cVe00j7Qjj+9Wdbtut9pq7ppxJnvmqi7szkm02z0/T2xHG3tWoCWZVHQ1h6dIBbRGtu0O5w3bFerBnxGKjaTZczjAp1NXB5p1WecwooooEFFFFABRRRQAUUUUAFFFFACV8jftA2efiVeMR96JD/Ovrg9a+XvjzHu+IM5/wCmKenvXTh92dmEjzcyf9akPgj9mm5kMVx4nu0iU8mFOTXvnhP4e+HPC8aDTdPj8xf+WjjJrraK5rnLzNbDW4GBURUk9ambpUJODzSY4j1GKcKReRS0xMUniq0pJzUx54pjrTvYqOhla1cSWOj6jeRqrSW1tJMgboWVSQD7cVzVp8QtHjstMTVbgw309tbTXIit5GitjOoKF3A2opJwCTXTa/BJd6FqdrAA089rLFGCcAsyEAZ+przY+D9bHhrxDZ/ZYftF7pmm2sI84YeSGMLICewB796Vy5N3On8IeIrrxDq/iZAEhs9NuzZW8bW0iPuUfM7s2AwJPCr0A9xWXpGqeLB4n1ez1jU9D/s7Ro4bi7eGwkV5Y5EdiFy52lQnoc10XhixutOl19rxAq3eqS3UGG3bo2RACfTlTxVBdEvJNe8ZzsEjttWsre3tpC2cssUqsSOoALihvsNJtXZa1HxdoNjaLeXeoCK3azW/V/Lc/uCyqHwBnlnUY681hWfxC06412+0+98+1iEtuts72kqbFlRSv2gkYiLOSqhsZ49a5e58NeKNX062gn0NLM2WlW2mgS3SN50kd1DI7Lj+DbGSCeT0wK1/Fuia/qGo+KNMtdLVtN8QT2zJqfnrtt0RYxIZE+9kBPkxnJPbrStqNTlozuyMMVzyDzntVgcR5HWo3IaViFPJJqQDoAKyWjO+T2INxaQZBpt9h1xjnFSTMwf7tVm3PKd1O/c0gtVIYJhFbHaPwrntTiZ0M8Z2sOcV0DxgRN6+lQSwb7Jtq5OO1TPVWfqdlGpGm+bzPLtYdiGmUnOOc1mWN2ogxnJIPStPxWv2dJFJwSK5OFnj8rI4I5rnbb3PSqx5o8r66sqeIiQiyc8v2rh/GcisqDIzt6eleiazb+ZZK23jt9a8v8UBvtbb1wAvFbU3fU8jFP3W+/5HNLyhHFenfCC2X7PdTHl2cKPpXmjoVIwK9l+ElsItDaQ/ekk4+lGIfuM4sDBOrd9DsZk3jaOfrVeK2Jct05rbgs1c9OKWezCqAq8+teY09z6jDyUF7R7swokZrnk/KOlaDkIAQBkdKVrcRLxyTUDqcbQeaW2rPTh7keZ7spmN3dnz8xOcVdtYg6rgcnrTre3Jckg+1WbdCJPlHGaaTepMIc3vSJ4x5TBccVeiGwgrUUqAY9xT4Sc4681pHR6hJprQ7rSJCbVB1rpLI7QAe4rndBTNsvrW/bk71z2r0qZ8TjrObSNNBgU6mp0p3etjxmFFFFABRRRQAUUUUAFFFFABRRRQAV8rfHyfb8Q7hQRxCnp719U18g/tBT4+Jd6vpGg/nXRh92dWGly8z/rc+vqKKK5zlCoZBzU1MkHFJji9RFOBTicioR1HNSjihMqSEx3qN27VKTUDDmmOIwqCaim4PSpc4OM0jqGHNI2Ts9Ri4ZaaRjpTwAo+amseeMUrFIjKDBOahlcdFNSyuelQInzZxzSZtHuxVXaOB1pm/Dnn6inTB927J+lV0AEmSM5rNuxrFXVxWcl8HGaRgqSLuPJpxVVfJHWoZ3TzVbv0o9TSOuiK1+7Bxg8GtDTYjJafLyMcj0qrIBLk44WrGlXJVZI422gmrj2fzKq3dK0d0eW/EWwf7arL9wferjZwpvY0QYUDHFetfEGz3W7tH2Ga8stYHy8jDnPesasXf1PWpz56Mdd9yHXW8vT1WMfd9K8m8XXHmPGuMMq85r2K4hSSBg7dsj614t4yl8zWZeAAMDirprqebi5Xg5fJGRGA5Ga9k+F0gOneT02tXjVt/rAO/bmvV/hy4jDKTyeSKzxPw2McvjzTsewW4Ai4A5qfyleMjFZunSGUgZraiUbcY4FcS1Pei+aXN0RiXkG3HtWb5YWQs2c11F1b7huYcfSsW7hAOFrN6vyPQw8/bSvLYgH3SQefWnW+C3Bpi5VD3xUlnHhi2MUlLsdFWdlaJZIyhyfmxUsC/dxTSPnyeRirdugyAPUVauznd0rs7PQjiFR7Vuw8uD2rD0ngKB0xW6g+UV6dLY+Pxn8Rmov3RR3psRygp/Wtzx3uFFFFAgooooAKKKKACiiigAooooAK+J/2h70f8LT1MBuioP0r7XJAUk9BX58/GS//ALQ+JOuTKcgTlR+FawfLFs1g7Qk/T9T9B6KKKyMgpG6UtB6UAQYw1KDk0hPNIc9ak1JTjFV5B1o3knGaG6U7jirMjC80rDjnpSbxT8ZFBpqRlQRkVC2QcAVIzY70h5wc0mWtCJi3ccVG8nICDFWJADjNVpuDkHipZrCzEn6jJ5ptvkkkjgdM09mAXLdaheXy4+eSahmiTasQ3Lnz8dqjdC7Ag9KW2XzJMtwKsbVzhaSVzob5NERJGfJbHX0qlZMyXOD8ua2C6pjHNZrDF7lhgmq5bdR0p8ykmUPFnNvtZuMV5dcHZIcfcJxXpni0E2p2jJ2nFeSi5Y70l5O41FVu+u7PSor/AGVRW7/Iz9ZncnbG21sYJrxnxKjQ6jKrnLAnLete631l5kMkigNiPP5V4j4sUvqLu3JJyaqG/kebjHzU7rZGRYNmYcd816P4KvQt0Ezg+teZA+Ucjmun8LXf+lIxP3T+FKtG8bnPgqjjLk6s+hNDfgH866NS7wyCFlSUodjsMhWxwT7ZxXF+HrrzYIyOcjrXYQwx3FlLDOm+KZGjdT/EpGCK81fyn0D+FU4nn+hyw6Te2Y1UazpetQwSvfm5Zp4NV2oWYxvkruBG8AAEDjGKox+P2ntp5Ta2NzM1oLyCCyuvMKguq+VKcfK/zqeOOo7V2kHhKby7O31XVpdR0uxDC1tngVG5QxgySA5cqjMBgDrk5Nc3rvha+h8OXlrFqV3qBS3jtbSJIliZEEinc2OHkAA+Y44HTk10TnTvY5KKxFKNoab9u39f5FHUdV1k6lZaeYbSC+h1G2S4EcrGKWGVWK4JGeqsCPVR61e/4S1l0myvfsIxcpduU8z7vkIzD67tuPbNWpPDM7O1zNqbS6obuG6N19nATEQIVPLz93DNnnOWJ9qqL4MBRIW1S4ayiW5S3hESgxCdSG3N/GRuOOnvms4xp7s7uXFLWN9fTv8A5EVx4p1m1gupZtKsdtpaQajKEuGJ8iT+Acf6wYPPTivQIRsc85FYF34UhvLS/je6mX7bYQ6exCj5Vjzhh7nPPauhQYlORitZ8mnKXh/bLmVV3+46/RPmCkntW6HAOB0rC0VtsCkdRWpAzSSd8V1xaSPncXG9Rs2YOVFSiqsD7Uwasr61qjx5qzHUUUUyAooooAKKKKACiiigApM0tIaAMvxNff2d4e1C7Jx5ULt+lfnHq9017q17cscmWZm/WvuX9oLWP7H+GmpuG2vMvlr75r4Nj5B+tay0gl3NprlpxXe7/T/M/T6imROssSSIcq6hgfY0+sjEKD0oooAicVG1SuOKiapNYjRUcjdqfnFQuwB60rmsVqIeDTmlAXFRuRtzVd5RRc1UOYmMgPWl3DtVVmz7ULKR3ouaezLO7HJqKUrsJ71G0lVp5s8AipbLhTbZIJOOc1FO6Hjkt6Cq8srxpkkGkikL42jn1rJyu7HUqVveJ4yVz6mpA20kHqaidxGBnlqTzBwaadhON9SaRxuUZAxVe/lAUOMbqbNcBAWwCaxdSvSY8557CiVRRWpvQw7nJDNcvXliZMgkLXksg3X7qeu/tXol/LjT55W+Zwua81srhVuJJZcZLZFYc7bu+p6dSmoUvZx3OxmtQmkBzjO3FfPfiWzkGsXKt0BOBXvFzqsF1YLDG3O3mvJdftxdXVzdQscRnp610RkrWR5FSPOnfZHnF0GRirDBFWtKuPJmGDVnXvJYI0a7ZOhFZdv/AK1B3zWnxI8nWlUuj6L+H5aeyhJ5yM16dZR5wDwK4H4W2jLo0MjAfdGMV6PbgAcjJHf0ryb8rbPqo+5TV92OmARPmxjHArAuZN8hGMVoXbSXEx2nEa/rUL2paQN0PpSjH7UjpoJU9ZbmewZhxTkX1HNaLWwAy3T2pEhBAyOKmU7uyN/bJoYh2xgetNb/AFucc1YkjIAxjApsiYx61d2ZKWp0uh4NuAT2ratV2MfesXR+IE9624AQ2W716VN3SPmsZ8ci2pw+O1XFYBc9qqdBlsVZVdyDPStkeTUJFbd06UtIoAXApaoxYUUUUAFFFFABRQaavSgB1MZgDzSs2BVaaURxPI5wqgkmqjG5cYtnzN+2B4j3Np2iQvx/rZAD+VfMkf3fxruPjV4g/wCEi+IGpXSNuhR/LT6CuHj+7+NVV+Ky6GmItz8q2Wn9fM/QH4HeJF8T/DrTbovumhXyJM9crxz+Fd9Xyb+yH4tW01i98O3UmEuv3kAJ/iHUV9ZVddXlz/za/wCf4mL7hRRRWAhjdKhbIFTkc1DIKhmkCvI1VJW5zU0x5xVSVgBUtnbTiSswK89KoyygHg8VI7fIaoSsQ2ahux10adyysw9aepzzWcH/ACqdJgopRl3NpUrbE8hPY4NQYIbJpHdT1JpDKoHHNEmOMWhHIk+g60wyrGM9Kie58sEDGapyy5BL1i5JHRCk3vsTzTl2yDxQsx28nistp8sQpyKSS4IXA61n7R9DrWH0sX7q4+XisPULgcKxG4ngUl1diNCXOT2ArDvrtYYzNMcyH7q1lKpc7qGHVNczLOr3sa2rwKRkj5sV5yzhpHWMfKTgVs3rubSWeQkO5wBWXBBlRIe3X3q43td7mOJsvcW7MK/vJrVJF3leMVTsZAdNn342kcmrPjCMxorjqeK5a71QQWXkK3B5Y1tFNqyPKqOK0eyMPWB8xPfNU7VT5i8ZzT7mY3Mo9K09AsWvNQt4EH35Av6113stTxWva1bo+lvhrB9m8LWIkPzMu5jXa5V48RZIHU1zmg2621pDAudsaha6+xgzF8uAPevLgvaSbex9HOTjFSkUYoN5IzgVF5ZJO3kirkjeVIyLyT1NQsAoODgdTjvUTk5uyNIze5BLnZg4plr1YnPFMmYlhjNSpu8gkjBrSnTSd2bPSNu5DOxD8dKZkFeTzSSEkn0pinGMVbinqaqOh1WjMPIBIzity3BlOc4UVzejyAQ/Wuksd2wZ6V1UH7tj5vHR5ZNlibmMY4GatQthADVdxnAHSl37etdGzPLkuZWLooJxUUT5A9akYccVRg1Z2FBzS02PpTqBMKKKRjigQjE5wKYWGOPxodiBUXJq0jRRHZ9a4T41eIV8N+ANQuVcLNKhij57mu6xxXyf+1n4sF3qlroNtLmOD55QD3rSOnvdjel7rc+359D55nlaaZ5XPzOSxoj+7+NR1JH938awOQ1vCOtzeHfE1jqlsxV7eUMcdxnmv0W8N6vb67odlqVowaK4jDjHY45Ffmg33j9a+rf2SPG6z2Vx4YvZf3sZ8y33HqO4reHv03DqtV+v+fyKWqsfStFFFYEiHpUMlTmoZBUsqG5nXPGazppK0bwfKTWPMTuIrGTseth1dEobIqtdYC05W28VHd8pmovodcI2kU2k54o87g9Kqyybc471CCc/1rHnPQVJNF4TdahkuMZw2fpVSecKNoxVGa52qcHk1nOobU8NzF6a5jQlnJJ7AVTMsty542pVe0jaebL5P1q3fSCFPKhwHI5PoKzTlI6uSNN8q3I5bhIQVTlqz7m9x/EC3oKpXE6DcqSbjnkjqax73UIbRTlhvP4mpszVcqL91ebfmY5fso7Vl/8AHxdKbhuM5PsKzf7T3MWAH1NVpb9nc7CWJ6mhIJ1ftfcams3CXDhIQBDHwPc1TkUxRxoDye1Vo51iHm3BC4+6CelYGueKY4Sy237yY9+wreKbPLrVOXS+pQ+IeoCKNIkxu/lXnTebO2Tk89K1bpri+uTJNudic1PBZuq8RnPauyFoKx4dbmrztH4UZsVqUGTxiu3+GFmtx4ntzt4jBYe5rno7F2IyrfTtXcfDNFtfEEIHLEHPFZ15+4zpwOG5qqvse96TbL8qce9dA9wlnFgDcccAVz+n3CI+8NkYrXhQyoZn5LfdHpXDCXMuWB6eJjeV5bEMm6Yb2wuecDtUacFgw+lWJI5VTLJgUkcRzuc5Zug9BWtlAlSVinKgGGpZfmgAHBNPuQ5cAY25pkvDY7AVn7V3Nk72KhTLfSowgAz6mrKjhiag+/JgVpCVzeMrmppr4THpXU2EpaIZ44rkbAFXIJrprD7i+ldVPRnjZhBM1VYHj8abKp4IqKP72DVoEMtdT1PGl7rHW7A4NWxyKpJgDircbArSRz1FrceBiigHNFUZCE4FIFzyaHAOAaUMKYxrqMVEv3uanPSqzmmmXDUzfF2sQaH4fvdRmYKsMZYe5xxX53+K9Xl1zxBe6hOxZ5pGbJ9M19DftU+OGV4vD1hPjA3TBT39K+YqqWi5TWt+7iqfzf6BUkf3fxqOpI/u/jWZzDG+8frW94F8RT+FvFFhq1sTmCQFgD95e4rBb7x+tJVQk4SUl0GnZ3R+l3hbXLTxHoVpqmnyB4J0Dcdj3BrVr5M/ZS+IIsb5/DGpS4guDut2Y8K3pX1nV1YpPmjs/wCrfIckt0FNdcinUVkTsZ10hIIrBvB5bGuluFHOawNUTqRWFRaHqYKetmUo2yeelRXbjbTVPOM1FcuOneue568Ye8UbhvlJqDzAUNS3Z4HrVbacVg3qelTS5dRoTe3NRzWylxiraR4xz1prRs9wir0zzQoXL9o09GMu5ItMsGmkIHGc14p4v8b3V7cSQaZIY4QcGQdWrufjVeS2ujpBGxUOcHBrxOJQVyn3q6FTSV2edPFPVR3NjT/EN/bkK0rFD1Oa2FvrOVfMlldn75Nc3BAX4YAH1NXYbddu0qPr61i4rdCWJm1aTL82q2wBEaE4pieIBbRkRWpdz/Ew4FRpBGv3Ux68U/7OGwAo5paB7WUjEvru61CQmZ9qnqoqEWcQ29/Wuja1iXgBdx74qxDpcT4dzziq5raIzcW9DAt7IDnGB+lWDbnouMVsvaAMBGcjtVmKwULluWo5nsNwXwxMP7NtXgAkd6v+EgYNZV1HzHIAq7Lbrt4U5qx4Xsh/aqMwPHNZ1Ze6zooK9RQiek6UCxBk+U9celdLb3Cjau4k9gK5u2jdgAuSxre0y3KnMnBrlhPkVkd2KhG2prxzPLhWUBR60XKqiDHHPJqRHVFwVAOOKo3l0nCswOK3ScleR5MIuUvdWhDNx82eaqSSjaT71PKQy5BrP2szn0p+zPQpRTWpIG3DFT2kXVveoIgATWlaICnHaiMWpCqtQWgkYxIAOprd06X5QDng1hRtun3Y4BrUtP8AWfL+NdyelzgxUeaOpuceYG9qmGAgxVKF8nB4q6i/IT2FdMXc8Sorbj1BBAqxGwzg1SEmX4qVDyT3poxlHuXl6UtMU5xSM3BqrHNbUazfPQ/y80wN+8onfimjRLVIlU/JXJ/EXxRbeEPDF5qd0wDKpEa/3m7CukilAjO44AGSa+Nf2l/H3/CR+JP7JsJc2FkSpweGfuauNt2a00oNzlsvxPJfEmr3Gu61dajeOWlncsfasyiis27u7OaUnJ3e4VJH938ajqSP7v40hDG+8frSUrfeP1pKALWm30+m30F5aSGOeFw6MD0Ir72+Cnj6Hx14UindlGoQAR3CZ5z6/jX5/wBdt8J/HN54G8UW97A7fZHYLcR54Za2pyTXs5bP8H/W5cGn7rP0NpCazfDmtWXiDR7fUdNmWW3mUMCp6e1X2bArJxcXZicWnZkVweKyr1MoeK0pDmqVxyp9axnsdlD3Wc1L8jGqUpy3NaWoJhjgVlSZ69K4paH0VBqSuV5zjBIo3DbxSylf4qbHEx5HSs7anZfQlBwoNb0GkyQ2iTTBVDYIOc1iRxh/wrWtIJGCklmRegJOBXRSSvqjgxM5W912PGvjpP5txb2qdRyT6V5MsJ57Y717t8V9GNzMtxEhwB83FeST2PJG3mtq2iVjnpR5lczI3lQ+3rWlaygjliT0xUAt9uAcjP6VNPCqEGIlhwSa45anQoWWpqwRkgHPB7U94eMgke1ZltcuuAGzWhFPnBOfpmovbRlRjqSQ2EkjDaPxNX1tnRdu0nHamW1yxOBxWpFKuACRk0tDRprRFOGzc8leKupCyrylWEOcEEH6VZQgAbzkVSSM5t2tEx5xjgrWh4cixI0pAB6VDeEclRkmtbwzFlfn6elZYh8qsdeBSjO6Os0p1GONzGtlUeT5g3T0rNs0VTwNorWB2Q/uzmpo09LyDEy966IQskh/eN0pxt0IJxkmlQPnJ6mnlvTrW/Okc7b6FOSPHTj2qm7bW4rTkO4HHUVSlQE571PtLnRSl3IYzkH3NakEmyI+uKzkUbhnoOatuwEGeMVqldXCslLQdGCJBmtW0OJAAcVlRPkg9qvBtpGODV0pXi0zkrxb0NUfe4qxazMx2E1QguBtwetJFP5cuO9dMZbM82VJtNGiH2TGre7AzWaHLqW71aR8IN3pWqZzVIbF2OYA89Kl3hl61lFstgHiraNiLg5q0zCdJLUdI+G4qOSYbcZ5qtPIxbr0rmvHvii08KeHbjU71wNgwiZ5ZuwFNauxvToc1jjPj58R18K6BJpunyj+07tSoweUXua+NZZHmkaSRizscknvWx4v8QXfibXbnUr5yzysSBnhR2ArEpylfRHJiaqm+WHwr8fMKKKKg5gqSP7v41HUkf3fxoAY33j9aSlb7x+tJQAUUUUAe1fs8/FKTwjqy6VqkhbSbpsZJ/1TetfZsVxHcwJPA6vE4DKynIIr8yQcHIr6S/Z2+Lxtmh8N+Ipswn5badz93/ZNbX9ordV+J0U7VPde/Tz8j6hfGKqyjrU5dWUMhBU8giq8rEjjmueaN6adzLvo8qawrjliK6C6J2EE1h3CYkziuCrue3g3pqUAAzhW4+tWQpAA/gqtc8HO3kVNHJviFZp2O6pdq6NKyhD4wK6C0iCIAQKw9NcDGK3FcbPeuylY8XFuTdjnfEdiXWVJBujcce1eJeINJeyunwuUJ64r6FnIkUq4BrjNe0RLjcxAI9Kup7xth5Nbnh8yDb93nvUHlZGBzXaatoOyU7Bj8Kx5dKdGPeuCUbHoJJ7GD9nzkqBT0RuRtNaxsXXoOvtU0Fn82X4rNsHCxnRGRRwDVmOWTgYzWza2YJAxkVrW2lRsRlV/xqlqZSnbY5qG5YHkHFaKX8agBuc+lbkujoMBYwQeuKWLR7eLDCID3NUoW1RjKrfRGQYJJYvOYEKegrpNAtsRKVznrTL4xxwiNMZrY8OpkDjmsay1TZ6GDnyU5GzZWpkUNJ0PatBYlQbTjHapFjAjBAwcVHO25OMgiqV2jjlUdSRFgcgVC5pAWU/MaZM2ORS5TWMdSOR8Cq7NgjPOaHfrnrTMbnHqKlxOpRsibbhfrUcrHyyPepwMr16VXYlmAxitqburBF3Zbt8kL6VZLFnwvGKrQkqoHvUqkr071dLqjnmrstlxGwBPNAfbMrdqilALD6ZobgJ+tbReyMOVGrG5MZY8GniUsnpVaRsQqq+lQLMc4J4FbqVkcip82pfRs55qeOVsHbnFZHnEA+hNWZLuK2tHnnkWOKNdzMxwAKpSuxTosfquo2+nWMt5eyrFbxKXdmPAAr4w+MnxCn8a66yxMyaZbkrCnr/tGt/45fFGTxLdPpOkSMmlxNhmHBlI/pXjVbXsjz8VWUF7KHz/AMv8woooqTzgooooAKkj+7+NR1JH938aAGN94/WkpW+8frSUAFFFFABTkZkcMhKsDkEdqbRQB9J/Aj4y+WsOgeKbg44W3uXP5Kxr6SWRJI1dGDKwyCORX5tglSCDgjoa98+C/wAaW0lIdG8Tuz2fCxXJOSns3tTl72vU9CjWVX3Z/F+f/BPqG4QMpIFY93HhjgVqWl1De2yT2siyQuNyspyCKiuo9w4FclSPMehQm4OzMORN45HNR+XtTAHFXJ4yMnmqzsxG0YGK5NYvU9RPmWha05xvAPrXQoAwxXLWrFGGQc1vWc+7HfFdFKR52Kg73Q+4t2VDtrNdQyFCMHvW40oAw4rPmRA5ZQcmtpRurozoVHszm7zSlmz0zWHdaKFJwoNdo8ffGRioHRGX5l5rmlG+56MKpw7aYB0UD8Ko3WnbeQvSu5ltkJ6DNVZrNGB4Oa53HU6lJSOIhiaJxn8q2LbbIFxx7Ut9YspJAqvAGjPtU6pmVWF1obEMbY4zinyWuRlj2qK0uwAAetWHmBGK2i0cTi09DLubLB3YzWx4bXaPXBwap3MyiMgda0vDjD7O/rms6iTOmndRbZ1aqHjHb0pkluCp4p1mrCMFz+FWScjBraMlax5spOMtDGmhG3ANULsbF4rbmixGSOcVk3K5rKbsd+HqXZkSkqCxqS3JCZJ5NNvDkbV7GmK25RjIHpUpnpr3oloOce1DqMqR0qumcDFT7tyj2ohpIhxs9CeBizcVOSQcGqlnIC5qzIwDDB4rohuznnH3rEjHGKcZMFQBTWIyM0Pg4q49DKy6lvf8oFQb9rHNErY2gVU1G9t7G1luLyVYoYxlmY4FO+liIQuT3E8cMTzTuscMY3u7HAAHevmn4y/Fh9faXR9BZk05Gw8oODLj09qpfGH4oz+IppNL0eRotKQ4Zl4Mp9/avJK6acWtWeVjsby3pUn6v/L/ADFPJ5pKKK0PGCiiigAooooAKkj+7+NR1JH938aAGN94/WkpW+8frSUAFFFFABRRRQAUtJRQB6z8Ifi7e+EJo7HUy91pDHGCctF7j/Cvq/Q9c03xDpsd7pV1HcQuM5U9PY+lfnvXR+DfGOseEdQW60m5ZBn54ico49xSlFSO6hi7WjU+8+65FB4IqrLADn1rgPh38WdH8WwJBdOtlqeMNC5wGPqpr0UEEZByK46kO57VOenNF6FEqV4OfrV2yuFjYA8UFVbqKa1sD2rJJxehc3GaszUMism4mq0zBgcVU87y8I/Snxyhj7V0e0ujnjS5RCWUcdKRkJ5p+Sz4A49aSTcPuce9YyRsmV2XnpzUbLuB7Grqpxg9agljYHp+VZuL6GsZ62M+eJGUhxmsO+tTGSVHy100kRZfes+dAoKyDA9aiSOqnJS0MGJRj3qVm+QjPPrS3SiObKY203bvB2jj0pIxnCzKk77QASCa3vDEnljLjIrPSyVznAFaWnIImx2FNwbLjZxaZ1UTvLyPlWrS4VQM5rLgldhhOAOpq5ErZ4bIrVI82pCwtw3y4HSsu4wScVoTcdKzpFO45/OiUTahoZV0gD59arEEE9hWjMBnmsy6yshIrBxsz0ac7OxLE3NBlKo1V1ckipCQwK0PudMkrktq/wCAq3FKGyD+FUEGAKeGw1Wm+YmcFJmhvDLz2pwbcox1rPdzjg1x/jr4m6V4UtWiR1utRIwsKHofc1pC8mkjmqRVOPNJ2R12v+ItP8P2Ml3qtwkUaDIBPJ9gK+Xvif8AEu98XXLQW5a30xD8sYPL+5rmfFvirU/FF+1zqc7MCfljB+VR7CsCu2nT5VrufPYzMue8KOi79X/kgooorU8gKKKKACiiigAooooAKkj+7+NR1JH938aAGN94/WkqZkXceO9JsX0oAioqXYvpRsX0oAioqXYvpRsX0oAioqXYvpRsX0oAioqXYvpRsX0oAbFI8UivEzI6nIYHBFeyfDj42X2jCKx8RK95ZD5RMD+8Qe/qK8d2L6UbF9KTSejNqOInRd4M+7PDfiTS/ENml1pN3HPGwzgHkfUdq6BMEV8FeGtVv9I1KKXTLua2ctyY2xn6ivsr4f6hdahoVvLeTGWQgZYgDP5VhOnye8j2qFdYmLaVmjorqMNzjpVNS8Z+Uda05BkVUkUc8d6wnG6udlKWlmOjn4561IJB64FVJAMCo+h4rFSa0L9mnsaSSAnk0rSDb0zWepJJyafk7etaxqdDN0hGYtIRjHvVW6QyAqw+WrCdKRwCtZvU3i+VnPXdoQx2k4qKBWjbBFa90BuNVCo44rK2p0y1jdimQBc4FQR3LS5+XDA8VK4GOlVsbZMjg1rdmMUk7nS6ZITEEfr3rXQbVz3rntNY561t5O3rVQOSvH3h0rBx71VdPWnmll+4KpasiPumTdjHSsy45GMc1qah0NZU1RUidkHpcrI3zdamzjmqzdRQSeOaxasjtveKLbOAc1Q1bV7LSrdri/uY4UXn5jiq+tXEtvYSvC5VgpINfLnjHU73UNWn+23MswViAGbgfhWtKk6j3MsbjI4OmptXuei+O/jE88cln4dBRDlTcHr+FeM3M8t1O81xI0krHLMxySaNi+lGxfSvQp0401aJ8hi8dVxTvN6duhFRUuxfSjYvpWhxkVFS7F9KNi+lAEVFS7F9KNi+lAEVFS7F9KNi+lAEVFS7F9KNi+lAEVSR/d/Gl2L6VJGi7enegD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal nasal examination by anterior rhinoscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5760=[""].join("\n");
var outline_f5_40_5760=null;
var title_f5_40_5761="PUPPP striae";
var content_f5_40_5761=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F67980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F67980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    PUPPP striae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5761=[""].join("\n");
var outline_f5_40_5761=null;
var title_f5_40_5762="Calcaneovalgus feet";
var content_f5_40_5762=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Positional calcaneovalgus feet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Geraldo Cabrera-Meza, Baylor College of Medicine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5762=[""].join("\n");
var outline_f5_40_5762=null;
var title_f5_40_5763="Advanced ECG test";
var content_f5_40_5763=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Advanced ECG test",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5763/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5763/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5763/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5763/contributors\">",
"     David M Mirvis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5763/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5763/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/40/5763/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;An 85 year-old man is found in his room. He is noted to be obtunded with a slow heart rate. An electrocardiogram is obtained and a specific diagnosis is suggested (",
"    <a class=\"graphic graphic_waveform graphicRef61961 \" href=\"UTD.htm?41/35/42554\">",
"     waveform 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef69976 \" href=\"UTD.htm?19/20/19784\">",
"     waveform 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CASE 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rhythm strip is obtained from a patient with chronic (congestive) heart failure treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    . What is the arrhythmia (",
"    <a class=\"graphic graphic_waveform graphicRef81170 \" href=\"UTD.htm?26/53/27479\">",
"     waveform 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef60806 \" href=\"UTD.htm?26/5/26707\">",
"     waveform 4",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CASE 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following electrocardiogram is most likely to be associated with which one of the following diagnoses (",
"    <a class=\"graphic graphic_waveform graphicRef71975 \" href=\"UTD.htm?43/28/44490\">",
"     waveform 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef51943 \" href=\"UTD.htm?32/10/32938\">",
"     waveform 6",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Posterior myocardial infarction",
"     </li>",
"     <li>",
"      Aortic regurgitation",
"     </li>",
"     <li>",
"      Idiopathic pulmonary arterial hypertension",
"     </li>",
"     <li>",
"      Acute pericarditis",
"     </li>",
"     <li>",
"      Anterior wall ischemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CASE 4",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 43 year-old man with end-stage renal disease presents with fatigue, dyspnea, and increased jugular venous pressure. What electrocardiographic finding is present (",
"    <a class=\"graphic graphic_waveform graphicRef58594 \" href=\"UTD.htm?42/24/43402\">",
"     waveform 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef71377 \" href=\"UTD.htm?23/9/23705\">",
"     waveform 8",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CASE 5",
"    </span>",
"    &nbsp;&mdash;&nbsp;What arrhythmia is seen on the rhythm strip (",
"    <a class=\"graphic graphic_waveform graphicRef53548 \" href=\"UTD.htm?29/28/30151\">",
"     waveform 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef66364 \" href=\"UTD.htm?40/12/41155\">",
"     waveform 10",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CASE 6",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient with slowly progressive chronic (congestive) heart failure presents with the following electrocardiogram. What is the diagnosis (",
"    <a class=\"graphic graphic_waveform graphicRef72997 \" href=\"UTD.htm?42/17/43290\">",
"     waveform 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef53035 \" href=\"UTD.htm?18/17/18713\">",
"     waveform 12",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Posterior wall myocardial infarction with left anterior hemiblock",
"     </li>",
"     <li>",
"      Atrial septal defect",
"     </li>",
"     <li>",
"      Mitral stenosis",
"     </li>",
"     <li>",
"      Right bundle branch block with diffuse ischemia",
"     </li>",
"     <li>",
"      Dextrocardia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CASE 7",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following electrocardiogram is diagnostic of which disorder (",
"    <a class=\"graphic graphic_waveform graphicRef63568 \" href=\"UTD.htm?41/26/42410\">",
"     waveform 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef76377 \" href=\"UTD.htm?6/48/6920\">",
"     waveform 14",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Right ventricular hypertrophy",
"     </li>",
"     <li>",
"      Wolff-Parkinson-White pattern",
"     </li>",
"     <li>",
"      Dextrocardia",
"     </li>",
"     <li>",
"      Acute inferoposterolateral myocardial infarction or ischemia",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CASE 8",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following electrocardiogram is most consistent with which disorder (",
"    <a class=\"graphic graphic_waveform graphicRef54392 \" href=\"UTD.htm?42/13/43226\">",
"     waveform 15",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef63096 \" href=\"UTD.htm?14/33/14873\">",
"     waveform 16",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic renal failure",
"     </li>",
"     <li>",
"      Anterior myocardial infarction, hyperacute phase",
"     </li>",
"     <li>",
"      Aortic stenosis",
"     </li>",
"     <li>",
"      Prinzmetal's angina",
"     </li>",
"     <li>",
"      Ventricular septal defect",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CASE 9",
"    </span>",
"    &nbsp;&mdash;&nbsp;What arrhythmia is present and what is the likely cause (",
"    <a class=\"graphic graphic_waveform graphicRef77993 \" href=\"UTD.htm?3/3/3126\">",
"     waveform 17",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef58111 \" href=\"UTD.htm?28/2/28704\">",
"     waveform 18",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CASE 10",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram in this 60 year-old man is most consistent with which diagnosis (",
"    <a class=\"graphic graphic_waveform graphicRef72757 \" href=\"UTD.htm?42/60/43978\">",
"     waveform 19",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef51306 \" href=\"UTD.htm?17/42/18090\">",
"     waveform 20",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mitral stenosis",
"     </li>",
"     <li>",
"      Chronic obstructive pulmonary disease",
"     </li>",
"     <li>",
"      Left posterior fascicular block",
"     </li>",
"     <li>",
"      Ventricular septal defect",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CASE 11",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 55 year-old woman has the following electrocardiogram (",
"    <a class=\"graphic graphic_waveform graphicRef64074 \" href=\"UTD.htm?41/14/42218\">",
"     waveform 21",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef74885 \" href=\"UTD.htm?39/36/40519\">",
"     waveform 22",
"    </a>",
"    ). What is the most likely diagnosis?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mitral stenosis",
"     </li>",
"     <li>",
"      Aortic regurgitation",
"     </li>",
"     <li>",
"      Anteroseptal myocardial infarction",
"     </li>",
"     <li>",
"      Bifascicular block (right bundle branch block and left posterior hemiblock)",
"     </li>",
"     <li>",
"      Atrial septal defect",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CASE 12",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following electrocardiogram is consistent with which condition (",
"    <a class=\"graphic graphic_waveform graphicRef50830 \" href=\"UTD.htm?42/5/43098\">",
"     waveform 23",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef65692 \" href=\"UTD.htm?9/56/10121\">",
"     waveform 24",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe chronic obstructive pulmonary disease",
"     </li>",
"     <li>",
"      Posterior myocardial infarction",
"     </li>",
"     <li>",
"      Normal neonatal electrocardiogram",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy",
"     </li>",
"     <li>",
"      Mitral stenosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CASE 13",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following wide complex arrhythmia is incidentally discovered during exercise testing. What is the arrhythmia and what is the underlying rhythm (",
"    <a class=\"graphic graphic_waveform graphicRef78439 \" href=\"UTD.htm?0/42/680\">",
"     waveform 25",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef56316 \" href=\"UTD.htm?22/6/22628\">",
"     waveform 26",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CASE 14",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 21 year-old man with chronic (congestive) heart failure has the following electrocardiogram. What is the diagnosis (",
"    <a class=\"graphic graphic_waveform graphicRef69076 \" href=\"UTD.htm?32/33/33306\">",
"     waveform 27",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef75704 \" href=\"UTD.htm?14/0/14346\">",
"     waveform 28",
"    </a>",
"    )?",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atrial septal defect",
"     </li>",
"     <li>",
"      Duchenne's muscular dystrophy",
"     </li>",
"     <li>",
"      Mitral regurgitation",
"     </li>",
"     <li>",
"      Idiopathic dilated cardiomyopathy",
"     </li>",
"     <li>",
"      Patent ductus arteriosus with Eisenmenger's syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CASE 15",
"    </span>",
"    &nbsp;&mdash;&nbsp;What arrhythmia is present on the electrocardiogram (",
"    <a class=\"graphic graphic_waveform graphicRef55762 \" href=\"UTD.htm?38/4/38986\">",
"     waveform 29",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef66450 \" href=\"UTD.htm?40/0/40962\">",
"     waveform 30",
"    </a>",
"    )?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CASE 16",
"    </span>",
"    &nbsp;&mdash;&nbsp;What U wave abnormality is present on this electrocardiogram (",
"    <a class=\"graphic graphic_waveform graphicRef82027 \" href=\"UTD.htm?7/58/8105\">",
"     waveform 31",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef61287 \" href=\"UTD.htm?38/20/39238\">",
"     waveform 32",
"    </a>",
"    )?",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2097 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9F1D191359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5763=[""].join("\n");
var outline_f5_40_5763=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CASE 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CASE 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CASE 4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CASE 5",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CASE 6",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CASE 7",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CASE 8",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CASE 9",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CASE 10",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CASE 11",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CASE 12",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CASE 13",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CASE 14",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CASE 15",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CASE 16",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2097\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2097|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/35/42554\" title=\"waveform 1\">",
"      Advanced case 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?19/20/19784\" title=\"waveform 2\">",
"      Advanced case 1 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/53/27479\" title=\"waveform 3\">",
"      Advanced case 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/5/26707\" title=\"waveform 4\">",
"      Advanced case 2 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?43/28/44490\" title=\"waveform 5\">",
"      Advanced case 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?32/10/32938\" title=\"waveform 6\">",
"      Advanced case 3 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/24/43402\" title=\"waveform 7\">",
"      Advanced case 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?23/9/23705\" title=\"waveform 8\">",
"      Advanced case 4 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?29/28/30151\" title=\"waveform 9\">",
"      Advanced case 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?40/12/41155\" title=\"waveform 10\">",
"      Advanced case 5 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/17/43290\" title=\"waveform 11\">",
"      Advanced case 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?18/17/18713\" title=\"waveform 12\">",
"      Advanced case 6 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/26/42410\" title=\"waveform 13\">",
"      Advanced case 7",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?6/48/6920\" title=\"waveform 14\">",
"      Advanced case 7 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/13/43226\" title=\"waveform 15\">",
"      Advanced case 8",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?14/33/14873\" title=\"waveform 16\">",
"      Advanced case 8 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?3/3/3126\" title=\"waveform 17\">",
"      Advanced case 9",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?28/2/28704\" title=\"waveform 18\">",
"      Advanced case 9 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/60/43978\" title=\"waveform 19\">",
"      Advanced case 10",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?17/42/18090\" title=\"waveform 20\">",
"      Advanced case 10 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/14/42218\" title=\"waveform 21\">",
"      Advanced case 11",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?39/36/40519\" title=\"waveform 22\">",
"      Advanced case 11 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/5/43098\" title=\"waveform 23\">",
"      Advanced case 12",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?9/56/10121\" title=\"waveform 24\">",
"      Advanced case 12 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?0/42/680\" title=\"waveform 25\">",
"      Advanced case 13",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?22/6/22628\" title=\"waveform 26\">",
"      Advanced case 13 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?32/33/33306\" title=\"waveform 27\">",
"      Advanced case 14",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?14/0/14346\" title=\"waveform 28\">",
"      Advanced case 14 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/4/38986\" title=\"waveform 29\">",
"      Advanced case 15",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?40/0/40962\" title=\"waveform 30\">",
"      Advanced case 15 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?7/58/8105\" title=\"waveform 31\">",
"      Advanced case 16",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/20/39238\" title=\"waveform 32\">",
"      Advanced case 16 with answer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_40_5764="Trigger avoidance in allergic rhinitis";
var content_f5_40_5764=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/40/5764/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5764/contributors\" id=\"au5875\">",
"       Richard D deShazo, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5764/contributors\" id=\"au6045\">",
"       Stephen F Kemp, MD, FACP",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/40/5764/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5764/contributors\" id=\"se952\">",
"       Jonathan Corren, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/40/5764/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5764/contributors\" id=\"de128\">",
"       Anna M Feldweg, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?5/40/5764?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ALLERGIC RHINITIS TRIGGER OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Allergic rhinitis, also known as hay fever, affects approximately 20 percent of people of all ages. The most common symptoms include nasal itching, watery nasal discharge, sneezing, itchy red eyes, sore throat, or hoarse voice.",
"    </p>",
"    <p>",
"     Allergic rhinitis is caused by a nasal reaction to small airborne particles called allergens (substances that cause an allergic reaction). In some people, these particles also cause reactions in the lungs (asthma), and eyes (allergic conjunctivitis).",
"    </p>",
"    <p>",
"     One of the first steps in treating any allergic condition is to avoid or minimize exposure to the allergens that cause the condition [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/1\">",
"      1",
"     </a>",
"     ]. The evaluation and treatment of allergic rhinitis is discussed in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      IDENTIFYING THE ALLERGEN",
"     </span>",
"    </p>",
"    <p>",
"     There are four major categories of allergens that trigger allergic rhinitis:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Pollens (spring and summer: trees, grass; fall: ragweed, tumbleweed)",
"      </li>",
"      <li>",
"       Insects (house dust mites, cockroaches, lady bugs)",
"      </li>",
"      <li>",
"       Animal allergens (skin, fur, feathers, saliva)",
"      </li>",
"      <li>",
"       Molds",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In some cases, it is easy to identify a person's triggers, based upon when symptoms develop (eg, during a particular season, after exposure to a dog or cat, etc). In people with year-round symptoms, it may be more difficult to pinpoint the allergen(s).",
"    </p>",
"    <p>",
"     The first step in the treatment of allergic rhinitis is to reduce exposure to allergens. The most common indoor allergens are dust mites and cat and dog dander [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/2\">",
"      2",
"     </a>",
"     ]. However, with indoor allergens, it may take three to six months to see an improvement in symptoms once triggers are removed; steps to reduce allergens are discussed later in this topic review. (See",
"     <a class=\"local\" href=\"#H3\">",
"      'Reduce exposure to triggers'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     First-line treatment also usually includes one or more medications (eg, nasal glucocorticoid sprays, antihistamines). Medications for allergic rhinitis and allergic conjunctivitis are discussed in separate topic reviews. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/51/20274?source=see_link\">",
"      \"Patient information: Conjunctivitis (pinkeye) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     If symptoms are severe or persist despite avoidance of the allergen, the person may be referred to an allergy specialist for further testing and treatment. Allergy specialists can identify each person's triggers, so that he or she can focus on reducing exposure to the triggers that are important for them.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      REDUCE EXPOSURE TO TRIGGERS",
"     </span>",
"    </p>",
"    <p>",
"     Once a person trigger(s) have been identified, the next step is to reduce exposure to those specific allergens. Triggers may be present at work or at home, although for most people, the home environment is the primary source. It is especially important to reduce exposure to triggers in the bedroom because most people spend a significant number of hours there. However, to be effective, changes must be made throughout the entire home (",
"     <a class=\"graphic graphic_table graphicRef53161 \" href=\"UTD.htm?31/33/32284\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Dust mites",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dust mites are a microscopic type of insect that lives in bedding, sofas, carpets, or any woven material. Dust mites do not bite and do not cause harm to humans, other than by triggering allergies.",
"    </p>",
"    <p>",
"     Mites absorb humidity from the atmosphere (ie, they do not drink) and feed on organic matter (including shed human and animal skin). They require sufficient humidity and nests to live in (which are not visible with the naked eye). Dust mite infestation is less common in dry climates, such as the southwestern United States.",
"    </p>",
"    <p>",
"     Exposure to dust mites can be reduced by encasing pillows, mattresses, box springs, comforters, and furniture in mite-impermeable barriers. When covering crib mattresses and children&rsquo;s mattresses and pillows, only tight-fitting, commercial covers intended for this purpose should be used. Home-made covers (for example, plastic sheeting fastened with duct tape) should",
"     <strong>",
"      not",
"     </strong>",
"     be used in children&rsquo;s beds, as these can come apart and children can become trapped or suffocate. Tightly woven fabrics with a pore size of 6 microns or less are very effective at controlling the passage of mite (as well as cat allergens). Fabrics with a pore size greater than 2 microns or greater still permit airflow [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/3,4\">",
"      3,4",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Mites can be eliminated by washing sheets and blankets weekly in warm water with detergent or by drying them in an electric dryer on the hot setting (",
"     <a class=\"graphic graphic_table graphicRef60923 \" href=\"UTD.htm?42/20/43339\">",
"      table 2",
"     </a>",
"     ). Exposure can be further reduced by vacuuming with a vacuum cleaner equipped with a HEPA filter, dusting regularly, and not sleeping on upholstered furniture (eg, couches). However, studies have yet to show that physical or chemical cleaning methods reduce mite levels to a degree that improves symptoms [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/5\">",
"      5",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Indoor humidity levels should be kept between 30 and 50 percent; inexpensive humidity monitors can be purchased at most hardware stores. Humidifiers make the problem worse and are not recommended.",
"    </p>",
"    <p>",
"     When possible, the amount of clutter, carpet, upholstered furniture, and drapes should be minimized and horizontal blinds should be eliminated in the rooms where the person spends the most time (bedroom, study, TV room). Washable vinyl, roller-type shades are optimal. For children, the number of stuffed toys in the bedroom should be minimized.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Animal dander",
"     </span>",
"     &nbsp;&mdash;&nbsp;Animal dander is made up of the dead skin cells or scales (like dandruff) that are constantly shed by animals. Any breed of dog or cat is capable of being allergenic, although the levels given off by individual animals may vary to some degree. In cats, the protein that causes most people's allergies is found in the cat's saliva, skin glands, and",
"     <span class=\"nowrap\">",
"      urinary/reproductive",
"     </span>",
"     tract. Accordingly, short-haired cats are not necessarily less allergenic than long-haired animals, and furless cats have allergen levels similar to furred cats.",
"    </p>",
"    <p>",
"     Other animals, such as rodents, birds, and ferrets can also trigger symptoms in an allergic individual. Pets without feathers or fur, such as reptiles, turtles, and fish rarely cause allergy, although deposits of fish food that build up under the covers of fish tanks are an excellent source of food for dust mite colonies.",
"    </p>",
"    <p>",
"     If a person is found to be allergic to a pet, the most effective option is to remove the pet from the home. Limiting an animal to a certain area in the house is not effective because allergens are carried on clothing or spread in the air. Once a pet has left a home, careful cleaning (or removal) of carpets, sofas, curtain, and bedding must follow. This is particularly true for cat allergens because they are \"sticky\" and adhere to a variety of indoor surfaces. Even after a cat has been removed from a home and it has been thoroughly cleaned, it can take months for the level of cat allergen to drop. For this reason, it may take months for the person's symptoms to fully reflect the absence of the pet.",
"    </p>",
"    <p>",
"     If it is not possible to remove the animal, measures can be taken to decrease exposure to the animal dander (",
"     <a class=\"graphic graphic_table graphicRef58126 \" href=\"UTD.htm?18/57/19355\">",
"      table 3",
"     </a>",
"     ), although none of these methods is as effective as removing the animal. Vacuum cleaners with a HEPA filter are effective in reducing cat and dog allergen levels in the home and can reduce symptoms [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/5\">",
"      5",
"     </a>",
"     ]. (See",
"     <a class=\"local\" href=\"#H10\">",
"      'Air filters'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Rodents",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mice and rats have proteins in their urine that can cause allergies. This applies to rodents that live in a laboratory setting as well as rodents that live in the wild.",
"    </p>",
"    <p>",
"     To reduce rodent allergen levels significantly, a combination of pest control methods, in combination with pesticides (eg, poison baits), are usually necessary. This includes keeping food and trash in covered containers, cleaning food scraps from the floor and countertops, and sealing cracks in the walls, doors, and floors.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Cockroaches",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cockroach droppings contain allergens that can trigger asthma and allergic rhinitis in sensitive individuals. Cockroaches thrive in warm, moist environments with easily accessible food and water. Unfortunately, efforts to control cockroach populations in infested areas are often less than successful. Still, certain measures are recommended, including:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Use multiple baited traps or poisons",
"      </li>",
"      <li>",
"       Remove garbage and food waste promptly from the home",
"      </li>",
"      <li>",
"       Wash dishes and cooking utensils immediately after use",
"      </li>",
"      <li>",
"       Remove cockroach debris quickly",
"      </li>",
"      <li>",
"       Eliminate any standing water from leaking faucets or drains",
"      </li>",
"      <li>",
"       Keep humidity levels less than 50 percent with a dehumidifier or air conditioner",
"      </li>",
"      <li>",
"       Consult a professional exterminator for large or recurrent infestations",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Asian ladybugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;Asian ladybugs were previously imported to the United States as a biological means of controlling aphids. It was anticipated that the insects would not survive the cold of winter; however, they adapted by moving inside houses when temperatures drop in the early fall. Allergies to Asian ladybugs have been increasingly reported as a source of seasonal indoor respiratory symptoms, particularly chronic cough, rhinitis, and asthma. Most cases have been reported in rural areas of the central, mid-western, and southern United States. The insects can also bite and cause local reactions.",
"    </p>",
"    <p>",
"     Asian ladybugs enter homes through external cracks and crevices, and then infest spaces within walls. They secrete a brown liquid that may stain walls and produce an unpleasant smell.",
"    </p>",
"    <p>",
"     Treating the exterior of the house with a chemical (pyrethroids) before cold weather arrives can prevent swarming of the ladybugs inside the home. Pyrethroids are similar to pyrethrins, which are derived from marigold flowers. Pyrethrins are broken down by the sun and do not significantly affect groundwater quality. More information about Asian ladybugs is available from the Ohio State University Office of Integrated Pest Management (",
"     <a class=\"external\" href=\"file://ipm.osu.edu/lady/lady.htm\">",
"      file://ipm.osu.edu/lady/lady.htm",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Indoor molds",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mold spores can trigger symptoms of allergic rhinitis in allergic patients. Mold thrives in damp environments. Area such as air conditioning vents, water traps, refrigerator drip trays, shower stalls, leaky sinks, and damp basements are particularly vulnerable to mold growth if not cleaned regularly. Most of the mold spores enter the home from the outside air. However, under certain circumstances, mold growth in the home can be significant and worsen allergy symptoms.",
"    </p>",
"    <p>",
"     To reduce the growth of mold in the home, it is necessary to remove existing mold and also to reduce humidity to prevent future growth of mold. Humidity can be reduced by removing sources of standing water and persistent dampness. Removing house plants, fixing leaky plumbing, correcting sinks and showers that do not drain completely, removing bathroom carpeting that is exposed to steam and moisture, using exhaust fans in the bathroom when bathing, and dehumidifying damp areas to levels below 50 percent are a few steps that can help to reduce or prevent growth of indoor mold.",
"    </p>",
"    <p>",
"     Indoor garbage pails should be regularly disinfected, and an electric dehumidifier should be used to remove moisture from wet or humid basements. Old books, newspapers, and clothing should be discarded or donated rather than stored. Water damaged carpets and wall or ceiling boards should be thrown out because it is difficult or impossible to eliminate mold in this situation, even with thorough cleaning.",
"    </p>",
"    <p>",
"     Mold thrives on soap film that covers tiles, sinks, and grout. Sinks, tubs, and other surfaces with visible mold growth should be cleaned at least every four weeks with dilute bleach [one ounce (30 mL) bleach diluted in one quart (one liter) of water].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Air filters",
"     </span>",
"     &nbsp;&mdash;&nbsp;Air filtering devices, including HEPA filters, other mechanical filters, and electrostatic filters, are widely advertised to reduce indoor allergens. These may be marketed as components of heating or cooling systems, as individual units for use in a room or area, or as units that are worn by individuals. These devices are expensive and none have been scientifically proven to significantly improve allergy symptoms. Certain types of air filters (eg, ionizers) produce ozone, which is a respiratory irritant for some people. These devices have not been proven safe or effective and are not recommended (",
"     <a class=\"external\" href=\"file://www.epa.gov/iaq/pubs/ozonegen.html\">",
"      www.epa.gov/iaq/pubs/ozonegen.html",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     There are several factors that interfere with how well air filters work, and these may partly explain why studies have shown mixed results:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Air filters do not remove dust mite allergens effectively because these allergens are relatively heavy and do not stay airborne for more than a few minutes, for example, after making a bed or disturbing a dusty cushion.",
"      </li>",
"      <li>",
"       Most air filters probably remove pollens and pet danders from the air because these allergens are light and remain airborne. However, if there is a pet, carpeting, upholstered furniture, access to outside air, or some other reservoir of allergen in the vicinity, the allergen is continuously released from these items as people move around the house. There are far more allergens in these reservoirs then an air filter can remove. Therefore, allergens continuously enter the air, even as it is being filtered, and the benefit of an air filter is minimal.",
"      </li>",
"      <li>",
"       In contrast, in a room where there are no carpets, drapes, upholstered furniture, access to outside air, and pets are not allowed, an air filter may improve air quality.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In addition, a vacuum cleaner with a HEPA (high-efficiency particulate air) filtration system and a double thickness vacuum bag can help to reduce allergen levels. This is recommended to avoid rebreathing the debris that is captured by vacuuming. A controlled trial has reported a reduction in cat and dog, but not dust mite allergen levels, and a clinical improvement in asthma and allergic rhinitis symptoms in homes cleaned with vacuums equipped with HEPA filters, compared to vacuums without specialized filters [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/5\">",
"      5",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      OUTDOOR ALLERGENS",
"     </span>",
"    </p>",
"    <p>",
"     Allergic rhinitis symptoms that worsen when outdoors and at certain times of year are likely to be triggered by an allergy to pollen, other plant material, or molds.",
"    </p>",
"    <p>",
"     Affected individuals should close the windows of the car and home, stay indoors when possible, and use air conditioners to filter the air during times of peak symptoms. Use of a high quality mask may be helpful for activities, such as grass cutting or wood cutting. These are also helpful in avoiding nonspecific irritants, such as dust and fumes, which can trigger sneezing. Showering before bed removes allergens from hair and skin and can help reduce contamination of the bedding. Over-the-counter saline sprays and rinses can be used after being outdoors to wash away allergens from the nasal lining.",
"    </p>",
"    <p>",
"     The American Academy of Allergy, Asthma, and Immunology has a toll free number (1-800-976-5536) and website (",
"     <a class=\"external\" href=\"file://www.aaaai.org/nab/index.cfm\">",
"      www.aaaai.org/nab/index.cfm",
"     </a>",
"     ) that monitors pollen and mold spore counts.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498783610\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181962667\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/2/16419?source=see_link\">",
"      Patient information: Avoiding asthma triggers (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/11/4275?source=see_link\">",
"      Patient information: Asthma in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/58/17315?source=see_link\">",
"      Patient information: Asthma in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/38/37474?source=see_link\">",
"      Patient information: Seasonal allergies in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/5/42066?source=see_link\">",
"      Patient information: Allergy shots (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/24/42370?source=see_link\">",
"      Patient information: Allergy skin testing (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/10/13475?source=see_link\">",
"      Patient information: Seasonal allergies in children (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181962726\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/51/20274?source=see_link\">",
"      Patient information: Conjunctivitis (pinkeye) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/48/34569?source=see_link\">",
"      Allergen avoidance in the treatment of asthma and allergic rhinitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=see_link\">",
"      An overview of rhinitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=see_link\">",
"      Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=see_link\">",
"      Pathogenesis of allergic rhinitis (rhinosinusitis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=see_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20119?source=see_link\">",
"      Primary prevention of allergic disease: Maternal avoidance diets in pregnancy and lactation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3914?source=see_link\">",
"      Recognition and management of allergic disease during pregnancy",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Institute of Allergy and Infectious Diseases (NIAID)",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"        www.niaid.nih.gov",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Allergy, Asthma, and Immunology Online",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.acaai.org/\">",
"        www.acaai.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aaaai.org\">",
"        www.aaaai.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Rhinologic Society",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.american-rhinologic.org/\">",
"        www.american-rhinologic.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?5/40/5764/abstract/1-6\">",
"      1-6",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 20, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?5/40/5764?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/1\">",
"      Sharma HP, Hansel NN, Matsui E, et al. Indoor environmental influences on children's asthma. Pediatr Clin North Am 2007; 54:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/2\">",
"      Platts-Mills TA. Allergen avoidance in the treatment of asthma and rhinitis. N Engl J Med 2003; 349:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/3\">",
"      Vaughan JW, McLaughlin TE, Perzanowski MS, Platts-Mills TA. Evaluation of materials used for bedding encasement: effect of pore size in blocking cat and dust mite allergen. J Allergy Clin Immunol 1999; 103:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/4\">",
"      Miller JD, Naccara L, Satinover S, Platts-Mills TA. Nonwoven in contrast to woven mattress encasings accumulate mite and cat allergen. J Allergy Clin Immunol 2007; 120:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/5\">",
"      Popplewell EJ, Innes VA, Lloyd-Hughes S, et al. The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress. Pediatr Allergy Immunol 2000; 11:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5764/abstract/6\">",
"      G&oslash;tzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998; 317:1105.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f5_40_5764=[""].join("\n");
var outline_f5_40_5764=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ALLERGIC RHINITIS TRIGGER OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           IDENTIFYING THE ALLERGEN",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           REDUCE EXPOSURE TO TRIGGERS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           OUTDOOR ALLERGENS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?31/33/32284\" title=\"table 1\">",
"           Allergen reduction PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?42/20/43339\" title=\"table 2\">",
"           Dust mites avoidance measures",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?18/57/19355\" title=\"table 3\">",
"           Animal dander avoid PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f5_40_5765="Niacin and simvastatin: Patient drug information";
var content_f5_40_5765=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Niacin and simvastatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/42/35495?source=see_link\">",
"     see \"Niacin and simvastatin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5925347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Simcor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027855\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower cholesterol and other harmful types of cholesterol in the body. Good cholesterol (HDL) levels rise.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691358",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower triglycerides.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to niacin, simvastatin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703203",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Active liver disease, bleeding problems, rise in liver enzymes, or ulcer disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696863",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease. Alcohol may cause more flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698093",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing. Taking aspirin or ibuprofen 30 minutes before taking this drug may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027859\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695902",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food at bedtime.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694547",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid hot drinks when it is time to take this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12039 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5765=[""].join("\n");
var outline_f5_40_5765=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5925347\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027855\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027857\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027856\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027861\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027862\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027864\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027859\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027860\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027865\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027866\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/42/35495?source=related_link\">",
"      Niacin and simvastatin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_40_5766="Candida pseudohyphae yeast";
var content_f5_40_5766=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Candida albicans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pseudohyphae of candida with budding yeasts are present on this potassium hydroxide preparation. Pseudohyphae are chains of elongated yeast cells that fail to detach after budding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5766=[""].join("\n");
var outline_f5_40_5766=null;
var title_f5_40_5767="Tuberculosis and the eye";
var content_f5_40_5767=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tuberculosis and the eye",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Rathinam R Sivakumar, FAMS, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5767/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5767/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/40/5767/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H5509035\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) is an infection caused by M. tuberculosis that can cause disease in many organs, including the eye",
"    <sup>",
"    </sup>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Ocular TB can involve any part of the eye and can occur with or without evidence of systemic TB. It generally develops following hematogenous spread from a primary focus, but in rare cases it can also occur as a primary infection following epithelial injury. Establishing the diagnosis of TB in an extrapulmonary focus is a clinical challenge.",
"   </p>",
"   <p>",
"    Issues related to ocular TB will be reviewed here. Issues related to other aspects of TB, including ocular toxicities of TB medications, are discussed in detail separately. (See related topics.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509042\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) is an airborne communicable disease of major public health significance in many countries. General issues related to epidemiology of TB are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/22/34150?source=see_link\">",
"     \"Epidemiology and pathology of extrapulmonary and miliary tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7497?source=see_link\">",
"     \"Epidemiology and molecular mechanisms of drug-resistant tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most TB disease involves the lungs. Ocular TB usually represents extrapulmonary dissemination of infection. The incidence of ocular TB is uncertain due to difficulties in ocular sampling for microbiology and inexact diagnostic criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Prior to the era of",
"    <span class=\"nowrap\">",
"     HIV/AIDS,",
"    </span>",
"    two prospective studies of patients with TB admitted to a sanatorium noted ocular disease incidence of 1 to 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Since the",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    area, prospective surveys have noted the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Among 100 patients with culture-positive TB in Spain who underwent systematic ophthalmologic evaluation, ocular TB was identified in 18 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/6\">",
"       6",
"      </a>",
"      ]. HIV coinfection was observed in 60 percent of patients, and more than half of patients had no symptoms referable to the eye.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Among 109 patients with TB and HIV coinfection in Malawi who presented with fever, indirect ophthalmoscopy demonstrated choroidal granulomas in approximately 3 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies suggest that routine ocular examination may be warranted for patients with suspected or proven TB, especially if eye symptoms are present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509049\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) of the eye may be intraocular or it may involve the external structures. Three manifestations of ocular TB have been described based on mode of transmission of bacilli to the ocular tissues.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Most commonly, ocular TB develops as a result of hematogenous spread of M. tuberculosis from pulmonary or extrapulmonary sites. The clinical manifestations consist of intraocular findings (",
"      <a class=\"graphic graphic_figure graphicRef57690 \" href=\"UTD.htm?41/35/42549\">",
"       figure 1",
"      </a>",
"      ); these include choroiditis, chorioretinitis, choroidal granuloma optic neuritis, optic disc granuloma, sub retinal abscess, orbital cellulitis, scleritis, necrotizing scleritis, posterior scleritis, sclerokeratouveitis (",
"      <a class=\"graphic graphic_picture graphicRef87839 \" href=\"UTD.htm?32/27/33201\">",
"       picture 1",
"      </a>",
"      ), interstitial keratitis, and anterior chamber granuloma (",
"      <a class=\"graphic graphic_picture graphicRef87840 \" href=\"UTD.htm?22/29/22993\">",
"       picture 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Less commonly, ocular TB can occur as a result of direct ocular infection from an exogenous source. In such cases infection may involve the ocular adnexa, lacrimal gland, conjunctiva, sclera, or cornea.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In rare cases, eye involvement can occur as a result of a hypersensitivity reaction to a distant focus of infection. Manifestations may include episcleritis, phlyctenulosis, and occlusive retinal vasculitis; the latter is similar to that observed in Eales&rsquo; disease. (See",
"      <a class=\"local\" href=\"#H5509133\">",
"       'Retinal TB'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16631?source=see_link\">",
"       \"Eales' disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509084\">",
"    <span class=\"h2\">",
"     Intraocular TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraocular TB most commonly affects the uveal tract, which includes the iris and ciliary body (anteriorly) and the choroid (posteriorly). The choroid is a vascular layer located between the sclera and the retina; it forms the middle or vascular coat of the eye. Anatomically, tubercular uveitis may present as anterior, intermediate, posterior, or pan uveitis",
"   </p>",
"   <p>",
"    The diagnosis of intraocular TB can be challenging as the clinical manifestations are variable. Definitive diagnosis of TB is established by isolation of bacilli from the ocular tissues, which is difficult to achieve. Therefore, a diagnosis of tuberculosis is frequently presumed in the presence of suggestive ocular findings (such as choroidal granuloma, broad-based posterior synechiae, retinal vasculitis with or without choroiditis, or serpiginous-like choroiditis) in combination with systemic findings consistent with TB (such as positive AFB smear and culture, consistent radiographic findings, or a positive interferon-gamma release assay or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    in individuals with no systemic symptoms) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/9\">",
"     9",
"    </a>",
"    ]. Clinical response to antituberculous therapy further supports a presumed diagnosis of ocular TB. (See",
"    <a class=\"local\" href=\"#H5509243\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20031029\">",
"    <span class=\"h3\">",
"     Uveitis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509091\">",
"    <span class=\"h4\">",
"     Anterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tubercular anterior uveitis is characterized by granulomatous keratic precipitates (",
"    <a class=\"graphic graphic_picture graphicRef87841 \" href=\"UTD.htm?6/39/6772\">",
"     picture 3",
"    </a>",
"    ), iris granulomas (",
"    <a class=\"graphic graphic_picture graphicRef88548 \" href=\"UTD.htm?3/20/3401\">",
"     picture 4",
"    </a>",
"    ), and broad based poster synechiae; occasionally hypopyon may be observed (",
"    <a class=\"graphic graphic_picture graphicRef87840 \" href=\"UTD.htm?22/29/22993\">",
"     picture 2",
"    </a>",
"    ). Cataract is a common complication. Glaucoma is not a common complication, although annular synechiae and iris bombe can cause secondary angle closure glaucoma. Untreated chronic anterior uveitis may result in phthisis bulbi (an atrophic, scarred globe).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20031053\">",
"    <span class=\"h4\">",
"     Posterior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choroidal TB is the most common form of posterior uveitis. It occurs most commonly in the presence of systemic TB, and in rare cases, it is the sole manifesting presentation of TB or the initial manifestation of systemic infection. Choroidal TB may be unilateral or bilateral. Three funduscopic patterns have been described (",
"    <a class=\"graphic graphic_picture graphicRef87842 \" href=\"UTD.htm?3/17/3346\">",
"     picture 5",
"    </a>",
"    ): solitary tubercle, miliary choroidal tubercles, or tuberculoma (a single large lesion that may mimic tumor and can lead to serous retinal detachment) (",
"    <a class=\"graphic graphic_picture graphicRef62218 \" href=\"UTD.htm?11/35/11825\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tubercles appear as ill-defined, yellowish-white elevated nodules. They vary in size from a pinpoint to several disc-diameters in size. The lesions can coalesce into larger, elevated choroidal nodules. Focal choroidal granuloma or diffuse subretinal abscess may be observed as elevated lesions in the fundus. Ultrasonography can demonstrate focal retinochoroidal thickening. As the lesions age, the borders become more distinct and the rim becomes pigmented. Multifocal chorioretinitis with pigmented scars often indicates a tubercular etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with choroidal tubercle(s) near or at the macula present with diminished visual acuity. Patients with choroidal tubercle(s) at sites not adjacent to the macula are asymptomatic and lesions may be identified incidentally on screening ocular examination.",
"   </p>",
"   <p>",
"    Serpiginous-like choroiditis (SLC) of presumed tubercular etiology closely mimics serpiginous choroidopathy (SC) (",
"    <a class=\"graphic graphic_picture graphicRef87843 \" href=\"UTD.htm?32/56/33666\">",
"     picture 7",
"    </a>",
"    ). Patients with SLC are more likely to develop multifocal scattered highly pigmented lesions with vitreous cells, in contrast to classic SC, which is characteristically less pigmented [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/10\">",
"     10",
"    </a>",
"    ]. It is important to exclude TB as the cause of serpiginous choroidopathy. Optic disc granuloma may be seen and it can mimic a sarcoid granuloma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20031021\">",
"    <span class=\"h4\">",
"     Immune recovery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune recovery uveitis (IRU) can occur among patients with HIV and TB in the setting of immune reconstitution due to antiretroviral therapy. IRU is has been described among patients with HIV and concurrent TB, cytomegalovirus retinitis, and varicella zoster ocular infection. Severe IRU resulting in globe rupture has been reported in a HIV patient with coexisting tubercular uveitis (",
"    <a class=\"graphic graphic_picture graphicRef88548 \" href=\"UTD.htm?3/20/3401\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/11\">",
"     11",
"    </a>",
"    ]. Additional issues related to immune reconstitution inflammatory syndrome are discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=see_link&amp;anchor=H9#H9\">",
"     \"Immune reconstitution inflammatory syndrome\", section on 'IRIS associated with mycobacterial infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509133\">",
"    <span class=\"h3\">",
"     Retinal TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous involvement of the retina alone is uncommon. More frequently, the retina is involved in the setting of choroidal TB as retinochoroiditis. The diagnosis of retinal TB is usually presumptive based upon clinical evaluation of the eye and evaluation for evidence of systemic TB infection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tuberculin (or IGRA) reactivity; biopsy of the retina is generally not possible. Exudative retinal hemorrhagic periphlebitis in a patient with uveitis is highly suggestive of tubercular etiology. Similarly, healed periphlebitis and perivascular healed chorioretinal scars indicate a tubercular cause (",
"    <a class=\"graphic graphic_picture graphicRef87840 \" href=\"UTD.htm?22/29/22993\">",
"     picture 2",
"    </a>",
"    ). Fundus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    angiography demonstrates retinal vessel wall staining and vascular leakage.",
"   </p>",
"   <p>",
"    Eales&rsquo; disease is a retinal perivasculitis affecting the peripheral retina of otherwise healthy adults. It is unclear whether this condition occurs as a result of TB disease or whether it reflects an independent retinal hypersensitivity reaction. In one study of 50 patients with Eales&rsquo; disease or a noninfectious ocular disease, M. tuberculosis DNA was demonstrated by polymerase chain reaction in 48 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16631?source=see_link\">",
"     \"Eales' disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509148\">",
"    <span class=\"h3\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granulomatous uveitis may also be seen in patients with herpes simplex or varicella zoster infection, phacoantigenic uveitis, sarcoidosis, syphilis, leprosy, Vogt-Koyanagi-Harada disease, and sympathetic ophthalmia. Other causes of choroidal granulomas include syphilis, sarcoidosis, and fungal lesions. Clinical manifestations of nontuberculous mycobacterial (NTM) infections also simulate TB [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509155\">",
"    <span class=\"h2\">",
"     TB of the external eye",
"    </span>",
"    &nbsp;&mdash;&nbsp;External eye structures can be involved in ocular TB including orbit, eyelid, lacrimal gland, conjunctiva, and sclera.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509170\">",
"    <span class=\"h3\">",
"     Orbit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of the orbit occurs most commonly in children, although rare cases have been reported in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/14\">",
"     14",
"    </a>",
"    ]. Frequent findings include a draining sinus tract",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic evidence of bony destruction [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509177\">",
"    <span class=\"h3\">",
"     Eyelid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis of the eyelid (tarsus) presents as an eyelid abscess or a chalazion-like mass. Occasionally, spontaneous drainage of the abscess forms a draining sinus tract [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/16\">",
"     16",
"    </a>",
"    ]. An apparent chalazion (granuloma of an internal sebaceous gland leading to a localized swelling) that recurs despite surgical excision should prompt consideration of TB.",
"   </p>",
"   <p>",
"    TB of the eyelid can also develop as an extension of cutaneous TB [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/17\">",
"     17",
"    </a>",
"    ]. The skin disease consists of subepithelial nodules (&ldquo;apple jelly nodules&rdquo;), scaly plaques, or, rarely, erosive ulcers with destruction of facial features [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/18\">",
"     18",
"    </a>",
"    ]. The eyelid is involved as an extension of infection from the surrounding skin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21034?source=see_link\">",
"     \"Cutaneous manifestations of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509188\">",
"    <span class=\"h3\">",
"     Lacrimal gland",
"    </span>",
"    &nbsp;&mdash;&nbsp;TB of the lacrimal gland can present as symptomatic dacryoadenitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/19\">",
"     19",
"    </a>",
"    ]; the presentation may be indistinguishable clinically from bacterial infection. Failure to respond to antibiotic treatment should prompt histopathology of the gland [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509195\">",
"    <span class=\"h3\">",
"     Conjunctiva",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous infection of the conjunctiva may present as an ulcer, subconjunctival nodule, pedunculated polyp, or tuberculoma (hard, nodular, non-ulcerating mass) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Diagnosis requires an excisional biopsy with histopathology and culture. The number of organisms is usually small, so acid-fast bacilli may not be observed. Phlyctenular keratoconjunctivitis is rarely seen in patients with active TB. It appears to be associated with tuberculoprotein hypersensitivity, but not with active ocular infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509202\">",
"    <span class=\"h3\">",
"     Keratoconjunctivitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous infection of the cornea presents with pain and photophobia. Examination of the cornea may demonstrate corneal erosion with stromal infiltration. Deep keratitis is characteristic of tubercular infection of the cornea. The disease may be associated with anterior uveitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    conjunctivitis. Local lymph nodes may also be enlarged [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509209\">",
"    <span class=\"h3\">",
"     Sclera",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculous infection of the sclera (external or fibrous coat of the eye) results from hematogenous spread. The diagnosis can be difficult to establish and primarily is based upon evidence of scleral inflammation in a patient with active TB at another body site (",
"    <a class=\"graphic graphic_picture graphicRef76194 \" href=\"UTD.htm?31/52/32576\">",
"     picture 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509229\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolation of M. tuberculosis by culture is the cornerstone for diagnosis of tuberculosis, although this is not always feasible. Even if a specimen can be obtained, it is often too small for all procedures such as Ziehl Neelsen staining for light microscopy or inoculation in liquid and solid media. Isolation of M. tuberculosis by culture may take 1 to 10 weeks; however, once growth is obtained, species identification and drug susceptibility testing are possible. Tuberculin skin testing (TST) and interferon-gamma release assays (IGRA) for TB infection may support a presumed diagnosis of ocular TB if positive; however, the test result cannot be used to confirm the diagnosis. Conversely, a negative result for any of these tests does not rule out disease.",
"   </p>",
"   <p>",
"    Biopsy specimens may be obtained for histopathological analysis either from the iris or by retinochoroidal biopsy. However, absence of acid-fast bacilli or of caseating necrosis in the biopsy specimen does not rule out ocular TB. In such circumstances, nucleic acid amplification (NAA) may be useful. Although no nucleic acid amplification test currently is approved by the US Food and Drug Administration (FDA) for any specimen other than respiratory tract secretions, many laboratories use validated NAA processes to support a diagnosis of extrapulmonary TB. Diagnosis based on detection of mycobacterial DNA through polymerase chain reaction (PCR) is becoming more widely used because of rapid, accurate results and the ability to perform the test using a very small sample [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. A positive result indicates the presence of M. tuberculosis nucleic acid; it does not establish viability of the organism. If interpreted in the clinical context of the case, a positive result strongly supports a diagnosis of ocular TB.",
"    <br/>",
"    <br/>",
"    Xpert",
"    <span class=\"nowrap\">",
"     MTB/RIF",
"    </span>",
"    is a nucleic acid amplification (RT-PCR) assay that rapidly detects the presence of both M. tuberculosis and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    resistance by PCR. This may become an important diagnostic tool for respiratory secretions, but has it not yet been used in ocular fluids for diagnosis of ocular TB [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5767/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    When such techniques are not possible, and while awaiting culture information, the diagnosis of TB is presumptive based on clinical eye examination and evidence of infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509243\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to treatment of ocular tuberculosis (TB) is generally the same as that for pulmonary TB. These issues are discussed in detail elsewhere. In general, where TB is considered strongly as a clinical diagnosis, treatment should not be delayed until culture data become available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The response to therapy usually can be gauged by the clinical examination and resolution of inflammation. In the setting of choroidal TB, lesions can resolve completely with treatment. Retinal TB is managed with antituberculous therapy together with systemic corticosteroids (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    40 to 60 mg of prednisone orally once daily) followed by a taper depending on the clinical response. Development of neovascularization warrants photocoagulation of the retina.",
"   </p>",
"   <p>",
"    Some favor administration of antituberculous treatment for two to four weeks without steroids, followed by assessment for clinical improvement and subsequent determination regarding addition of steroids. However, for cases in which a lesion is present near the macula or optic disc, administration of concomitant steroids is mandatory to save these delicate structures from rebound inflammation that may occur with antituberculous therapy alone. In such situations, absence of recurrence following completion of the treatment supports a clinical diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5509250\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ocular tuberculosis (TB) can involve any part of the eye and can occur with or without evidence of pulmonary or extrapulmonary TB disease. Ocular TB usually arises after hematogenous spread from a primary focus. (See",
"      <a class=\"local\" href=\"#H5509035\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Three forms of ocular TB have been described based on mode of transmission of bacilli to the ocular tissues. Most commonly, ocular TB develops as a result of hematogenous spread of M. tuberculosis from pulmonary or extrapulmonary sites. Less commonly, ocular TB can occur as a result of direct ocular infection from an exogenous source. In rare cases, eye involvement can occur as a result of a hypersensitivity reaction to a distant focus of infection. (See",
"      <a class=\"local\" href=\"#H5509049\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common manifestation of ocular TB is intraocular disease involving the uveal tract; choroidal tubercles are the most common clinical manifestation. (See",
"      <a class=\"local\" href=\"#H5509084\">",
"       'Intraocular TB'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A diagnosis of ocular TB most often is a clinical diagnosis, with ocular findings supported by a consistent risk history for TB, evidence for TB elsewhere (such as the lungs),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a positive test for TB infection such as the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      (TST) or an interferon gamma release assay (IGRA), since culture of eye tissue or fluid frequently is not possible. A positive TST or IGRA may support a clinical diagnosis of TB, but it does not establish the diagnosis. Conversely, a negative test result does not rule out active TB. (See",
"      <a class=\"local\" href=\"#H5509229\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of intraocular TB includes herpes simplex or varicella zoster infection, phacoantigenic uveitis, sarcoidosis, syphilis, leprosy, and sympathetic ophthalmia. Other causes of choroidal granulomas include syphilis, sarcoidosis, and fungal lesions. (See",
"      <a class=\"local\" href=\"#H5509148\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      External eye structures that can be involved in ocular TB include the orbit, eyelid, lacrimal gland, conjunctiva, and sclera. TB of these structures can occur as a result of hematogenous spread or via extension of adjacent infection involving the skin or the sinuses. (See",
"      <a class=\"local\" href=\"#H5509155\">",
"       'TB of the external eye'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biopsy specimens may be obtained for histopathological analysis either from the iris or by retinochoroidal biopsy. Absence of acid-fast bacilli or of caseating necrosis in the biopsy specimen does not rule out ocular TB; in such circumstances, nucleic acid amplification may be useful. (See",
"      <a class=\"local\" href=\"#H5509229\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to treatment of ocular TB is generally the same as that for pulmonary TB. In general, for circumstances in which TB is considered strongly as a clinical diagnosis, treatment should not be delayed until culture data become available. The response to therapy can be gauged by the clinical examination and resolution of objective sites of clinical involvement. Retinal TB is managed with antituberculous therapy together with systemic corticosteroids. (See",
"      <a class=\"local\" href=\"#H5509243\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22642386\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Michele Trucksis, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/1\">",
"      Thompson MJ, Albert DM. Ocular tuberculosis. Arch Ophthalmol 2005; 123:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/2\">",
"      Yeh S, Sen HN, Colyer M, et al. Update on ocular tuberculosis. Curr Opin Ophthalmol 2012; 23:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/3\">",
"      Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol 1993; 38:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/4\">",
"      Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol 1967; 64:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/5\">",
"      Goldenburg M, Fabricant ND. The eye in the tuberculous patient. Trans Sect Ophthalmol Am Med Assn 1930; 135:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/6\">",
"      Bouza E, Merino P, Mu&ntilde;oz P, et al. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) 1997; 76:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/7\">",
"      Beare NA, Kublin JG, Lewis DK, et al. Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol 2002; 86:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/8\">",
"      Vasconcelos-Santos DV, Rao PK, Davies JB, et al. Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol 2010; 128:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/9\">",
"      Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010; 149:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/10\">",
"      Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology 2003; 110:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/11\">",
"      Rathinam SR, Lalitha P. Paradoxical worsening of ocular tuberculosis in HIV patients after antiretroviral therapy. Eye (Lond) 2007; 21:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/12\">",
"      Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease. Invest Ophthalmol Vis Sci 2000; 41:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/13\">",
"      Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/14\">",
"      Pillai S, Malone TJ, Abad JC. Orbital tuberculosis. Ophthal Plast Reconstr Surg 1995; 11:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/15\">",
"      Sen DK. Tuberculosis of the orbit and lacrimal gland: a clinical study of 14 cases. J Pediatr Ophthalmol Strabismus 1980; 17:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/16\">",
"      Raina UK, Jain S, Monga S, et al. Tubercular preseptal cellulitis in children: a presenting feature of underlying systemic tuberculosis. Ophthalmology 2004; 111:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/17\">",
"      Mohan K, Prasad P, Banerjee AK, Dhir SP. Tubercular tarsitis. Indian J Ophthalmol 1985; 33:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/18\">",
"      Dinning WJ, Marston S. Cutaneous and ocular tuberculosis: a review. J R Soc Med 1985; 78:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/19\">",
"      Madhukar K, Bhide M, Prasad CE. Tuberculosis of the lacrimal gland. J Trop Med Hyg 1991; 94:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/20\">",
"      Panda A, Singhal V. Tuberculosis of lacrimal gland. Indian J Pediatr 1989; 56:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/21\">",
"      Cook CD, Hainsworth M. Tuberculosis of the conjunctiva occurring in association with a neighbouring lupus vulgaris lesion. Br J Ophthalmol 1990; 74:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/22\">",
"      Singh I, Chaudhary U, Arora B. Tuberculoma of the conjunctiva. J Indian Med Assoc 1989; 87:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/23\">",
"      Fernandes M, Vemuganti GK, Pasricha G, et al. Unilateral tuberculous conjunctivitis with tarsal necrosis. Arch Ophthalmol 2003; 121:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/24\">",
"      Aclimandos WA, Kerr-Muir M. Tuberculous keratoconjunctivitis. Br J Ophthalmol 1992; 76:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/25\">",
"      Sheu SJ, Shyu JS, Chen LM, et al. Ocular manifestations of tuberculosis. Ophthalmology 2001; 108:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/26\">",
"      Saini JS, Sharma A, Pillai P. Scleral tuberculosis. Trop Geogr Med 1988; 40:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/27\">",
"      Nanda M, Pflugfelder SC, Holland S. Mycobacterium tuberculosis scleritis. Am J Ophthalmol 1989; 108:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/28\">",
"      Wroblewski KJ, Hidayat AA, Neafie RC, et al. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology 2011; 118:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5767/abstract/29\">",
"      Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm 2009; 17:351.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organiation. Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Policy Statement file://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf (Accessed on March 04, 2013).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7999 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-04C97D187A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5767=[""].join("\n");
var outline_f5_40_5767=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5509250\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509035\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509042\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509049\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5509084\">",
"      Intraocular TB",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20031029\">",
"      - Uveitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5509091\">",
"      Anterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20031053\">",
"      Posterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20031021\">",
"      Immune recovery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509133\">",
"      - Retinal TB",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509148\">",
"      - Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5509155\">",
"      TB of the external eye",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509170\">",
"      - Orbit",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509177\">",
"      - Eyelid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509188\">",
"      - Lacrimal gland",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509195\">",
"      - Conjunctiva",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509202\">",
"      - Keratoconjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5509209\">",
"      - Sclera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509229\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509243\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5509250\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22642386\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7999\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7999|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/35/42549\" title=\"figure 1\">",
"      Eye anatomy in cross section",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7999|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/27/33201\" title=\"picture 1\">",
"      Sclerokeratitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/29/22993\" title=\"picture 2\">",
"      Anterior chamber granuloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/39/6772\" title=\"picture 3\">",
"      Anterior uveitis due to ocular TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/20/3401\" title=\"picture 4\">",
"      TB granuloma and immune recovery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/17/3346\" title=\"picture 5\">",
"      Choroidal TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/35/11825\" title=\"picture 6\">",
"      Tuberculoma of the eye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/56/33666\" title=\"picture 7\">",
"      Serpiginous-like choroiditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/52/32576\" title=\"picture 8\">",
"      Scleral tuberculosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21034?source=related_link\">",
"      Cutaneous manifestations of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=related_link\">",
"      Diagnosis, treatment, and prevention of drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16631?source=related_link\">",
"      Eales' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7497?source=related_link\">",
"      Epidemiology and molecular mechanisms of drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/22/34150?source=related_link\">",
"      Epidemiology and pathology of extrapulmonary and miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/35/23098?source=related_link\">",
"      Immune reconstitution inflammatory syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_40_5768="Microcystic adnexal carcinoma perineural invasion";
var content_f5_40_5768=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Microcystic adnexal carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 357px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Perineural and intraneural invasion in microcystic adnexal carcinoma (center). Extensive perineural invasion is a hallmark of microcystic adnexal carcinoma. Invasion of muscle tissue is also present (bottom right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5768=[""].join("\n");
var outline_f5_40_5768=null;
var title_f5_40_5769="Ligation uterine vsls 1";
var content_f5_40_5769=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67904%7EOBGYN%2F82120%7EOBGYN%2F57683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67904%7EOBGYN%2F82120%7EOBGYN%2F57683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ligation of uterine vessels during laparoscopic hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Lyons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ligation of uterine vessels during laparoscopic hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Lyons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ligation of uterine vessels during laparoscopic hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Lyons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5769=[""].join("\n");
var outline_f5_40_5769=null;
var title_f5_40_5770="Anatomy and pathology of testicular tumors";
var content_f5_40_5770=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anatomy and pathology of testicular tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Michael H Weinstein, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Michelle S Hirsch, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Philip W Kantoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/40/5770/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/40/5770/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular neoplasms comprise the most common solid malignancy affecting males between the ages of 15 and 35, although they represent about 1 percent of all solid tumors in men [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/1\">",
"     1",
"    </a>",
"    ]. The two main categories of testicular tumors are germ cell tumors (GCTs), which account for 95 percent of cases, and sex cord-stromal tumors.",
"   </p>",
"   <p>",
"    Testicular pathology is a nosologically complex subject because of the spectrum of histologic subtypes and variable clinical behavior, particular among GCTs. Prediction of biologic behavior depends upon the type(s) of tumors present, as well as clinical features, including the age of the patient and primary site (ie, testicular versus retroperitoneal), since histologically identical tumors can behave differently depending upon these clinical parameters.",
"   </p>",
"   <p>",
"    A second source of confusion is the nonuniform and often complex classification schemes for testicular tumors. Separation of a few of the major subtypes can be somewhat subjective (eg, there can be morphologic overlap between embryonal carcinoma and yolk sac tumor) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]; however, in many cases these distinctions may not be pivotal in the choice of therapy and management. The classification scheme used herein is relatively simple, practical, widely accepted, and of proven clinical utility (",
"    <a class=\"graphic graphic_table graphicRef81626 \" href=\"UTD.htm?43/42/44715\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Pathologic evaluation is generally performed on the entire testis rather than on a biopsy sample. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/63/33782?source=see_link\">",
"     \"Radical inguinal orchiectomy for testicular germ cell tumors\"",
"    </a>",
"    .) Examination of the entire testis allows identification of the histopathologic tumor type, as well as an assessment of the stage and extent of the disease, both of which have an important bearing on subsequent management and prognosis (",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 2",
"    </a>",
"    ). Histologic features that help to determine higher stage include vascular or lymphatic invasion and spread beyond the tunica albuginea or into the spermatic cord [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TESTICULAR ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The testis is composed of lobules of seminiferous tubules, interlobular septa, the mediastinum testis, rete testis, the tunica albuginea, and tunica vaginalis. The lobules are roughly pyramid-shaped, and each contains one to four U-shaped seminiferous tubules. Both ends of the seminiferous tubules empty into the rete testis, which is located posteriorly in the hilum of the testis, and drains into the epididymis. Normal seminiferous tubules have a basement membrane and a thin fibrous wall, and contain germ cells in various stages of maturation plus Sertoli cells. Blood vessels and lymphatics, mesenchymal supporting tissue, macrophages, and Leydig cells are contained within the intertubular interstitium.",
"   </p>",
"   <p>",
"    Lobules are separated from each other by fibrous interlobular septa, which contain blood vessels and lymphatics. A posterior expansion of the fibrous tunica albuginea forms the mediastinum testis, which joins with the confluence of the interlobular septa. The blood vessels of the interlobular septa, together with those of the tunica albuginea, drain into those of the mediastinum testis and ultimately into those of the spermatic cord. Overlying the external surface of the tunica albuginea and separating it from the parietal tunica vaginalis is the thin mesothelial layer of the visceral tunica vaginalis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not strictly part of the testis, the anatomy of the draining lymphatics determines the pattern of spread of testicular tumors. In the absence of prior surgery or invasion by tumor of the scrotum, the lymphatics of the testis drain directly to the retroperitoneal lymph nodes in a predictable fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=see_link&amp;anchor=H4#H4\">",
"     \"Retroperitoneal lymph node dissection in testicular germ cell tumors\", section on 'Lymphatic drainage and patterns of metastasis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GERM CELL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, GCTs account for about 95 percent of testicular tumors. They are near evenly distributed between pure seminomas (no nonseminomatous elements present), and all others, which together are termed nonseminomatous germ cell tumors (NSGCTs). NSGCTs may contain pure components (ie, only one subtype of malignant germ cells is present), or more commonly, they may consist of a heterogeneous mixture of two or more histologic subtypes. Distinction of these various subtypes of germ cell neoplasia is primarily a morphologic diagnosis, and the use of immunohistochemical stains should be reserved for difficult cases and not for routine diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Additionally, careful gross examination and thorough sampling of the specimen for histologic review is important, since accurate assessment of all tumor types may be crucial in planning management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Seminoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pure seminomas account for approximately 50 percent of all testicular GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ], and a seminomatous component is present in approximately 20 percent of mixed GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The average age at presentation for pure seminoma is approximately 40 years old (about 10 years older than for testicular NSGCTs). A seminomatous component is uncommon in GCTs in prepubertal males. Aside from age, there are no other reliable clinical correlates. In the ovary, a tumor nearly identical to seminoma is termed dysgerminoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific serum tumor markers are usually normal with seminomas, although beta-hCG may be somewhat elevated with tumors that contain scattered syncytiotrophoblastic giant cells. Nevertheless, in such cases, the serum beta-hCG is usually only mildly elevated (&lt;100 international",
"    <span class=\"nowrap\">",
"     units/L).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/58/38822?source=see_link&amp;anchor=H4#H4\">",
"     \"Serum tumor markers in testicular germ cell tumors\", section on 'Seminomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     \"Classic\" seminoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic characteristics of classic seminoma include a clonal proliferation of neoplastic germ cells that demonstrate well-defined cytoplasmic borders, central to marginally located nuclei with prominent nucleoli, and clear cytoplasm secondary to intracytoplasmic glycogen (",
"    <a class=\"graphic graphic_picture graphicRef74422 \" href=\"UTD.htm?0/39/631\">",
"     picture 1",
"    </a>",
"    ). This overall pattern at low power is often described as having a \"fried-egg\" appearance. The neoplastic cells of seminoma tend to be less cohesive than in embryonal carcinoma, yolk sac tumor, or choriocarcinoma, all of which are epithelial tumors. Additionally, clusters of lymphocytes are almost invariably seen in intimate association with the tumor cells.",
"   </p>",
"   <p>",
"    The differential diagnosis for seminoma includes lymphoma, especially with retroperitoneal tumors, and other GCT's, especially embryonal carcinoma (",
"    <a class=\"graphic graphic_table graphicRef81626 \" href=\"UTD.htm?43/42/44715\">",
"     table 1",
"    </a>",
"    ). The latter distinction is most problematic when a seminoma demonstrates cytologic atypia or is poorly preserved during processing.",
"   </p>",
"   <p>",
"    Immunohistochemistry is usually of great help in these situations. Traditionally, the use of cytokeratin and CD30 immunostains have been helpful in distinguishing seminoma from embryonal carcinoma, as only the latter should be positive for these markers. However, it is not infrequent for embryonal carcinomas to show only patchy or focal staining for cytokeratins and CD30, which in theory still raises the possibility of a mixed germ cell tumor instead of a one that contains a pure component.",
"   </p>",
"   <p>",
"    Additional immunomarkers that are now available can aid in the distinction of embryonal carcinoma from seminoma, as well as yolk sac tumor.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The transcription factors",
"      <span class=\"nowrap\">",
"       OCT3/4",
"      </span>",
"      and NANOG are very sensitive and specific markers that stain both embryonal carcinoma and seminoma but are negative in yolk sac tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/9-11\">",
"       9-11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sox-2 is a transcription factor that stains embryonal carcinoma, while being negative for both seminoma and yolk sac tumor (note that focal sox-2 staining has been observed in teratomatous elements and should not cause confusion; personal observation) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, c-kit immunoreactivity is present in seminoma, but is negative in both embryonal carcinoma and yolk sac tumor.",
"     </li>",
"     <li>",
"      Traditionally, AFP was used to stain yolk sac tumor, but background staining is frequently high, staining may only be focal, and focal staining can occasionally be seen in the non-yolk sac tumor components.",
"     </li>",
"     <li>",
"      More recently, a new stem cell marker, SALL4 has been shown to stain all subtypes of GCT (except teratoma and including spermatocytic seminoma) with high sensitivity and specificity [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/12-15\">",
"       12-15",
"      </a>",
"      ]. SALL4 is especially useful to distinguish yolk sac tumor from other GCT subtypes, and when a GCT is in the differential diagnosis of a metastatic tumor of unknown primary. In this regard, a primary or metastatic carcinoma that is SALL4 positive and negative for other germ cell markers, such as",
"      <span class=\"nowrap\">",
"       OCT3/4,",
"      </span>",
"      Nanog, Sox2, and AFP, would be immunophenotypically consistent with a yolk sac tumor. Of note, testicular sex-cord stromal tumors are negative for SALL4, and less than 5 percent of non-GCTs are focally and weakly positive for SALL4 (examples of the latter include rare SALL4 positive gastric, esophageal, and colonic carcinomas) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/12,13,16\">",
"       12,13,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Glypican-3 is another sensitive immunomarker for yolk sac tumor. However, studies demonstrate that it stains fewer tumor cells (ie, decreased sensitivity) when compared to SALL4, making the latter the preferred stain of choice for yolk sac tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Staining for HCG is usually supportive of a component of choriocarcinoma. However, it is not uncommon to find hCG-positive syncytiotrophoblastic giant cells in seminomatous GCTs, and their presence tends to correlate with a modestly elevated serum hCG concentration. This finding should be not be confused as implying the presence of a component of choriocarcinoma in the absence of other features characteristic of this type of GCT (eg, cytotrophoblast cells). The clinical significance of syncytiotrophoblastic giant cells in seminoma is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Anaplastic seminoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term anaplastic seminoma is no longer recognized by the World Health Organization (WHO). Instead, cases that were previously classified as anaplastic are included with the",
"    <span class=\"nowrap\">",
"     typical/classical",
"    </span>",
"    seminomas.",
"   </p>",
"   <p>",
"    This change in terminology is based upon the observation that the previously so-called \"anaplastic seminomas\" have similar outcomes when compared to classic seminoma of comparable stage with modern treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. It should be recognized, however, that some seminomas have increased cytologic atypia and a higher number of mitotic figures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Spermatocytic seminoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite being classified as a variant of seminoma, spermatocytic seminoma differs from classic seminoma in essentially all histologic, immunohistochemical, molecular, and clinical characteristics. This distinct clinicopathologic entity accounts for 1 to 4 percent of all pure seminomas and can occur in men of any age [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7,19-21\">",
"     7,19-21",
"    </a>",
"    ]. As an example, in one population-based study, the age at diagnosis among 58 cases identified ranged between 19 to 92 with a median of 54 years at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologically, spermatocytic seminomas have a characteristic admixture of three cytologically distinct populations of neoplastic germ cells of varying size (small, medium, and large), and nuclear features. Immunohistochemical staining for placental-like alkaline phosphatase (PLAP),",
"    <span class=\"nowrap\">",
"     OCT3/4",
"    </span>",
"    and c-kit is negative, in contrast to classic seminoma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/22\">",
"     22",
"    </a>",
"    ]. Although only a few cases have been tested, SALL4 has been show to be immunoreactive in spermatocytic seminomas [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike other classic seminomas, spermatocytic seminomas do not occur as part of mixed GCTs, do not contain an isochromosome 12p, and are not associated with intratubular germ cell neoplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/27/42425?source=see_link\">",
"     \"Testicular intratubular germ cell neoplasia, unclassified (testicular carcinoma in situ, testicular intraepithelial neoplasia)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spermatocytic seminomas have been shown to have a favorable prognosis even in the presence of lymphovascular invasion. The one significant adverse prognostic indicator is sarcomatoid differentiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Embryonal carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pure embryonal carcinoma accounts for about 2 percent of all testicular GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/23\">",
"     23",
"    </a>",
"    ], but it is a histologic component of approximately 85 percent of all mixed GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ]. The average age at presentation is approximately 30 years, similar to other NSGCTs. Embryonal carcinoma is rare in prepubertal males.",
"   </p>",
"   <p>",
"    Pure embryonal carcinomas usually do not produce alpha-fetoprotein (AFP). A more than modest elevation (ie, &gt;60",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    in the serum AFP concentration should prompt a suspicion that a concomitant element of yolk sac tumor is present [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/24\">",
"     24",
"    </a>",
"    ]. As with seminoma, syncytiotrophoblastic giant cells within embryonal carcinomas may cause a modest elevation in the serum beta-hCG concentration. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Yolk sac tumor'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Microscopically, embryonal carcinoma shows epithelial differentiation with cohesive clusters and sheets of cells that are immunohistochemically positive for cytokeratin at least focally. The cells usually show marked cytologic atypia, and this is often helpful in distinguishing them from yolk sac tumors, which generally exhibit blander cytomorphology (",
"    <a class=\"graphic graphic_picture graphicRef67376 \" href=\"UTD.htm?28/58/29607\">",
"     picture 2",
"    </a>",
"    ). Several architectural patterns exist, including glandular, papillary, and solid. None of these distinctions is of any clinical significance. Syncytiotrophoblastic giant cells may be present.",
"   </p>",
"   <p>",
"    The differential diagnosis is primarily with yolk sac tumor, which is often intimately associated with embryonal carcinoma, and, occasionally, with seminoma. Immunohistochemical (IHC) staining can be helpful (see above) with this, as well as in the broader differential diagnosis that may arise in metastatic deposits where non-GCTs are considered in the differential diagnosis. CD30 is the traditional marker used for embryonal carcinoma, but the use of recently described transcription",
"    <span class=\"nowrap\">",
"     factors/stem",
"    </span>",
"    cell markers,",
"    <span class=\"nowrap\">",
"     OCT3/4,",
"    </span>",
"    NANOG, Sox-2, and SALL4 are the most sensitive and specific immunomarkers for embryonal carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. However, one must be aware that both",
"    <span class=\"nowrap\">",
"     OCT3/4",
"    </span>",
"    and NANOG also stain seminoma, and that SALL4 stains all subtypes of GCT (",
"    <a class=\"graphic graphic_table graphicRef81626 \" href=\"UTD.htm?43/42/44715\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Yolk sac tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms \"yolk sac tumor\" and \"endodermal sinus tumor\" are synonymous. Pure yolk sac tumor is the most common malignant testicular GCT in prepubertal children [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/25\">",
"     25",
"    </a>",
"    ], although teratomas are actually more prevalent in this age group [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/26\">",
"     26",
"    </a>",
"    ]. Pure yolk sac tumor is rarely seen in the adult, whereas a component of yolk sac tumor occurs in about 40 percent of mixed GCTs in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nearly all yolk sac tumors are accompanied by increased serum AFP, usually &gt;100",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/24\">",
"     24",
"    </a>",
"    ]. Furthermore, the AFP level correlates with disease extent, with concentrations &gt;1000",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    often indicating the presence of extensive tumor. Yolk sac tumor does not produce hCG.",
"   </p>",
"   <p>",
"    Microscopically, yolk sac tumors are the most morphologically variable of all GCTs (",
"    <a class=\"graphic graphic_picture graphicRef70845 \" href=\"UTD.htm?3/58/4008\">",
"     picture 3",
"    </a>",
"    ). Although a wide variety of patterns are recognized (eg, microcystic, reticular, papillary, glandular, solid, hepatoid), their only significance is the degree to which they can make the recognition of yolk sac tumor difficult. Hyaline-type globules and Schiller-Duval bodies are most characteristic of yolk sac tumor, but they are present in a minority of cases. Typically, but not invariably, yolk sac tumors have lower nuclear grade, and may be associated with edematous to myxoid stroma.",
"   </p>",
"   <p>",
"    The most common entity in the microscopic differential diagnosis is embryonal carcinoma, with which yolk sac tumor often merges. Occasionally, difficulty may also be experienced in differentiating yolk sac tumor from seminoma or teratoma. Immunohistochemical staining for AFP can be helpful when present, and is generally positive, at least focally, in yolk sac tumor. However, high background staining for AFP is often high and can be positive in only a few scattered cells, at most, in embryonal carcinoma. The most specific staining profile for yolk sac tumor is the presence of SALL4 and AFP, and an absence of",
"    <span class=\"nowrap\">",
"     OC3/4,",
"    </span>",
"    Nanog, and Sox-2 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/11-14\">",
"     11-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Choriocarcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most aggressive type of GCT is choriocarcinoma. Widespread hematogenous dissemination occurs early, and many patients present with metastatic disease. Choriocarcinoma is present as an element of approximately 10 percent of testicular mixed GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ], but is rare in its pure form at this site [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/27\">",
"     27",
"    </a>",
"    ]. The average age at presentation is somewhat younger than for other NSGCTs, although testicular choriocarcinoma is rare or nonexistent in the prepubertal male.",
"   </p>",
"   <p>",
"    The serum beta-hCG concentration is often greater than 1000 international",
"    <span class=\"nowrap\">",
"     units/L",
"    </span>",
"    and may even be much higher. Choriocarcinomas do not produce AFP.",
"   </p>",
"   <p>",
"    Choriocarcinomas are characterized by areas of hemorrhage and necrosis, both grossly and microscopically. The most important diagnostic characteristic is the coexistence and intimate association of both syncytiotrophoblasts and cytotrophoblast cells, which distinguishes this tumor from other GCTs with only scattered syncytiotrophoblasts (",
"    <a class=\"graphic graphic_picture graphicRef57642 \" href=\"UTD.htm?7/0/7175\">",
"     picture 4",
"    </a>",
"    ). Recapitulating their normal embryonic function, the syncytiotrophoblastic giant cells and cytotrophoblastic cells often display extensive vascular invasion. This characteristic is presumed to account for the propensity for early hematogenous dissemination.",
"   </p>",
"   <p>",
"    Immunohistochemical staining for hCG is of limited utility in choriocarcinomas. While the syncytiotrophoblast is essentially always strongly HCG positive, this is diagnostically insufficient. Staining for hCG generally does not help to identify the crucial cytotrophoblastic elements, which are less conspicuous on H&amp;E-stained material, and at most are only weakly beta-hCG-positive. Choriocarcinomas is negative for",
"    <span class=\"nowrap\">",
"     OCT3/4,",
"    </span>",
"    Nanog, Sox-2, and c-kit, but SALL4 may be expressed in the neoplastic cytotrophoblasts (syncytiotrophoblasts are negative) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/13\">",
"     13",
"    </a>",
"    ]. Nevertheless, extensive sampling of GCTs and careful microscopic examination is the best way to detect this most aggressive tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Teratoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The designation teratoma refers to a varied group of tumors that show differentiation to form somatic-type tissues typical of either adult or embryonic development [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Testicular teratomas may present in both prepubertal and adult males, but the prognosis differs greatly between these two age groups. In children, teratomas most often occur before the age of four, are generally seen in their pure form, and behave in a benign fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults, teratomas are usually part of a mixed GCT, and they have the potential to metastasize. In this setting, the teratoma appears to have a common clonal origin with the other components of the GCTs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/29\">",
"     29",
"    </a>",
"    ]. Analyses of metastases from GCTs and teratomas from the same patient have demonstrated a high degree of concordance in the observed genetic abnormalities.",
"   </p>",
"   <p>",
"    Elevations in the serum concentration of AFP or beta-hCG cannot be attributed to teratomatous elements [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/24\">",
"     24",
"    </a>",
"    ]. Rather, elevated tumor markers indicate the coexistence of other GCT components.",
"   </p>",
"   <p>",
"    The pathology of teratomas is the most confusing of all testicular GCTs. This is because the clinical import of a given set of histopathologic findings can vary widely depending on the age and the site of the primary tumor.",
"   </p>",
"   <p>",
"    Few useful guidelines exist for testicular teratomas, in contrast to ovarian teratomas, where clinically meaningful criteria for the diagnosis of immaturity exist. Only immature teratomatous elements are considered malignant in an ovarian tumor, whereas both mature and immature elements are malignant in a testicular tumor. Thus, no distinction between mature and immature testicular teratoma is necessary. Teratomas with malignant",
"    <span class=\"nowrap\">",
"     (somatic/sarcomatous)",
"    </span>",
"    differentiation should be reported, since findings are suggestive of a worse prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For descriptive and recognition purposes, three \"variants\" of teratoma are described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Mature teratomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mature teratomas are composed of a heterogeneous collection of differentiated cells or organoid structures, all embedded in a fibrous or myxoid stroma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/30\">",
"     30",
"    </a>",
"    ]. Tissue types commonly seen within a mature teratoma include respiratory tract, gut, pancreas, thyroid, cartilage, squamous epithelium, and skin adnexal structures (",
"    <a class=\"graphic graphic_picture graphicRef63138 \" href=\"UTD.htm?22/56/23434\">",
"     picture 5",
"    </a>",
"    ). The degree to which undifferentiated mesenchymal elements can be present in teratomas that are termed mature is not clearly defined.",
"   </p>",
"   <p>",
"    Mature cystic teratomas (dermoid cysts), common in the ovary, are quite rare in the testis. These possess only squamous epithelium, skin adnexal structures (eg, sebaceous glands), and no immature elements. No metastases have been reported from dermoid cysts, even in adult males. Similarly, uniformly benign epidermoid cysts can be seen that contain only keratinizing squamous epithelium and no other (adnexal) elements. The lack of abnormalities in chromosome 12p may be useful in distinguishing epidermoid cysts from teratomas that have a potential for malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Immature teratomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immature teratoma can be defined as a tumor containing undifferentiated elements resembling tissue seen in embryonic stages of development. The degree to which the tissue must be undifferentiated is not clear. The presence of primitive neuroepithelial elements justifies the use of the term immature. However, the clinical significance of their presence in this setting is not well defined. Tissue with histologically frankly malignant features should not be included in this category.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Teratoma with malignant transformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A very small fraction of teratomas have malignant somatic-type tissue elements, such as squamous cell carcinoma, adenocarcinoma, or sarcoma such as rhabdomyosarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. Patients with tumors containing these features frequently present with metastatic disease. Teratomas with these features do not respond like other GCTs to cisplatin-containing chemotherapy. Instead, treatment must be tailored to the histology of the transformed lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34586?source=see_link\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Again, the diagnosis of \"mature\" versus \"immature\" teratoma is of little or no proven meaning in men with testicular GCTs. As an example, in children, the treatment for either mature or immature teratoma is surgical; the completeness of resection rather than the histologic grade of immaturity are the most significant prognostic parameter [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/37\">",
"     37",
"    </a>",
"    ]. Such tumors generally behave in a benign fashion, irrespective of the degree of immaturity, as long as there are no other GCT elements present [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/38\">",
"     38",
"    </a>",
"    ]. The finding of a significant component of a frankly malignant component (eg, rhabdomyosarcoma or adenocarcinoma) carries a distinctly poorer prognosis, especially when such a component metastasizes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As in the ovary, pure testicular neoplasms of types not usually primary to the testes are rarely seen (eg, carcinoid tumor). These have been termed \"monodermal\" teratomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Mixed GCTs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-third of all testicular germ cell tumors (GCTs) are mixed, with two or more germ cell tumor types present within a single mass [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ]. Every one of the 31 possible combinations of seminoma, teratoma, embryonal carcinoma, yolk sac tumor, and choriocarcinoma can be seen. A teratomatous component is identified in approximately one-third of all mixed GCTs, and the term teratocarcinoma has sometimes been applied to cases in which teratoma coexists with embryonal carcinoma. However, this term has largely been abandoned, and these tumors are referred to as a malignant mixed GCT, with a description of the specific germ cell tumor elements present.",
"   </p>",
"   <p>",
"    In adults, the epidemiologic and clinical features of mixed GCTs are similar to those of nonseminomatous GCTs (NSGCTs). The average age at diagnosis is about 30 years, and they are rare in prepubertal males. Elevations in serum alpha fetoprotein (AFP) and beta human chorionic gonadotropin (beta-hCG) reflect some of the components that are present within the tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Intratubular germ cell neoplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"intratubular germ cell neoplasia\" encompasses the presence of clearly malignant GCT elements within seminiferous tubules, and can include intratubular seminoma or less commonly intratubular embryonal carcinoma. However, a clear distinction of the intratubular component is not always possible and therefore these are often classified as intratubular germ cell neoplasia of unclassified type (ITGCNU).",
"   </p>",
"   <p>",
"    Morphologically, the in situ neoplasia often replaces all other germ cell elements. Occasionally, tumor cells may demonstrate pagetoid spread (",
"    <a class=\"graphic graphic_picture graphicRef71820 \" href=\"UTD.htm?17/31/17910\">",
"     picture 6",
"    </a>",
"    ). Intratubular neoplastic cells resemble their invasive counterparts cytomorphologically and immunophenotypically.",
"   </p>",
"   <p>",
"    The clinical significance of ITGCNU is not entirely clear. ITGCNU has been associated with GCTs of all types in adults, except for spermatocytic seminoma. The unanswered question is whether ITGCNU is a precursor lesion. There is evidence that it is [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/40,41\">",
"     40,41",
"    </a>",
"    ] but these data come mostly from areas (eg, Denmark) where the epidemiology of GCTs is somewhat different from that seen in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/42\">",
"     42",
"    </a>",
"    ]. Little or no comparable data exist from the United States. Thus, it is unclear how to manage a patient with no known GCT in a testis that shows ITGCNU on biopsy.",
"   </p>",
"   <p>",
"    ITGCNU is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/27/42425?source=see_link\">",
"     \"Testicular intratubular germ cell neoplasia, unclassified (testicular carcinoma in situ, testicular intraepithelial neoplasia)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Metastatic GCTs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic GCTs most frequently involve retroperitoneal lymph nodes and may differ histologically from the primary tumor. As an example, metastases from a pure testicular seminoma may contain only non-seminomatous elements at the metastatic site.",
"   </p>",
"   <p>",
"    There are at least three possible explanations for these histologic differences between the primary tumor and the metastasis. Because all of these tumors are thought to be derived from totipotential germ cells, the tumor may change its phenotype, possibly due to selection of a particular clone that gained the ability to metastasize. Another possibility is that the histologic tumor type in the metastatic focus was actually present in the primary tumor, but was not sampled for histologic examination. Last, metastatic teratoma is a frequent finding following chemotherapy even if the teratoma was not present in the primary testicular tumor because teratoma does not respond to chemotherapy, unlike the other nonteratomatous malignant germ cell elements. As with primary GCTs, elevations in serum markers are good predictors of the types of GCT present in metastases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Extragonadal GCTs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some GCTs present in extragonadal sites, such as the retroperitoneum, mediastinum, or central nervous system, without an evident testicular primary. At least some of these cases represent metastases from occult",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    regressed testicular primaries. However, germ cell tumors can arise in these extragonadal sites independent of testicular involvement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Molecular markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most consistent abnormality in men with testicular GCTs is the presence of an isochromosome of the short arm of chromosome 12 (i12p) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/43\">",
"     43",
"    </a>",
"    ]. Approximately 80 percent of NSGCTs and 50 percent of pure seminomas possess at least one i12p [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Most tumors in adult males with GCTS that do not have an i12p have other chromosomal abnormalities in this region that result in overrepresentation of chromosome 12p material [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/46-48\">",
"     46-48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of an i12p may be useful in establishing the diagnosis of a GCT in atypical cases, particularly for tumors arising in the mediastinum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SEX CORD-STROMAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular sex-cord stromal tumors (SCSTs) show differentiation towards Leydig cells, Sertoli cells,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other types of sex cord-stromal cells (eg, granulosa cells) (",
"    <a class=\"graphic graphic_table graphicRef81626 \" href=\"UTD.htm?43/42/44715\">",
"     table 1",
"    </a>",
"    ). SCSTs are much less common than GCTs, accounting for less than 5 percent of all testicular neoplasms in adults, but are somewhat more common in prepubertal males [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/49\">",
"     49",
"    </a>",
"    ]. In contrast to testicular GCTs, assessing the potential for malignant behavior is often difficult for SCSTs. Nevertheless, studies have shown that the likelihood for a given tumor to display malignant or metastatic behavior increases in the presence of local or vascular invasion, large size (ie, greater than 5 cm), large numbers of mitotic figures, cytologic atypia, and necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with GCTs, SCSTs exhibit numerous histologic patterns, and mixed tumors are relatively common [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/51\">",
"     51",
"    </a>",
"    ]. Morphologically recognizable elements include Leydig, Sertoli, granulosa, and theca cell types. Some SCSTs produce steroid hormones and are associated with specific endocrine syndromes, especially in prepubertal males. A minority of SCSTs exhibit some of the features of one or more of the histologic types of SCST but are not clearly representative of any recognized entity. Such cases are termed SCTS, unclassified type, and may be more likely to demonstrate worrisome features as described above [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical aspects of Leydig, Sertoli, and granulosa cell tumors are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6789?source=see_link\">",
"     \"Testicular sex cord stromal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Leydig cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leydig cell tumors are the most common type of testicular SCST. Up to 20 percent of Leydig cell tumors in adults are classified as malignant, based predominantly upon large size, vascular invasion, and increased mitotic activity. Malignant behavior has not been documented in children [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/50,53,54\">",
"     50,53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Microscopically, Leydig cell tumors consist of monomorphic sheets or nests of large cells with round, usually regular nuclei with a prominent nucleolus, and abundant eosinophilic cytoplasm. Occasional tumors may have spindle-shaped cells, or vacuolated cytoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/49\">",
"     49",
"    </a>",
"    ]. Eosinophilic crystals of Reinke may be seen in the cytoplasm in approximately one-third of cases, although they may be quite sparse and inconspicuous (",
"    <a class=\"graphic graphic_picture graphicRef82125 \" href=\"UTD.htm?16/0/16390\">",
"     picture 7",
"    </a>",
"    ). These crystals, which also have a characteristic appearance by electron microscopy, are characteristic of Leydig cells, but not diagnostic of neoplasia.",
"   </p>",
"   <p>",
"    The differential diagnosis for a Leydig cell tumor includes Leydig cell hyperplasia, malakoplakia, and other neoplasms, such as lymphoma, plasmacytoma, and, occasionally, a Sertoli cell or germ cell tumor. Immunohistochemical staining with inhibin (inhibin-A) can be helpful for the distinction from most germ cell and somatic tumors, but not from Sertoli cell tumors as these can also be immunoreactive with inhibin [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Additionally, calretinin and WT-1 immunostaining can be helpful; calretinin is more frequently present in Leydig cell tumors, whereas WT-1 is more frequently positive in Sertoli cell tumors. SALL4, a relatively new stem call marker that has been used to distinguish GCTs from other carcinomas and sarcomas, is negative in Leydig cell tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differential diagnosis also includes adrenal testicular rest tumors that are found in men with congenital adrenal hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link&amp;anchor=H11#H11\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\", section on 'Men'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sertoli cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general function of Sertoli cells is to facilitate spermatogenesis, and they are normally found scattered among germ cells within the seminiferous tubules. The secretory products of Sertoli cells include a variety of proteins.",
"   </p>",
"   <p>",
"    Sertoli cell tumors may be classified as either large cell calcifying or sclerosing types. However, the majority of testicular Sertoli cell tumors do not clearly belong in either of these two categories and are best termed Sertoli cell tumors, \"not otherwise specified\" (NOS) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/51\">",
"     51",
"    </a>",
"    ]. The sclerosing variant is the least common. Sertoli cell tumors can occur in any age group from infancy to old age.",
"   </p>",
"   <p>",
"    Large cell calcifying type tumors have very distinctive histologic features. The cells can be arranged in a variety of patterns, sometimes with tubule formation, and generally have abundant, eosinophilic cytoplasm, as the name implies (",
"    <a class=\"graphic graphic_picture graphicRef53394 \" href=\"UTD.htm?30/18/31015\">",
"     picture 8",
"    </a>",
"    ). Varying degrees of myxoid change or fibrosis can be seen in the surrounding stroma, and areas of calcification are usually a prominent feature. Neoplastic Sertoli cells are often present in the surrounding seminiferous tubules.",
"   </p>",
"   <p>",
"    In contrast, Sertoli cell tumors, NOS have a greater range of histologic appearance, making recognition of this group of neoplasms challenging. The cells exhibit a variety of cytomorphologic appearances, including small polygonal cells with scant cytoplasm, fusiform cells, and cells with abundant eosinophilic cytoplasm, which may mimic those of Leydig cell tumors. Furthermore, the architecture may also vary widely, with cells arranged in sheets, pseudorosettes, tubules, slit-like spaces, nests, or cords. A spectrum of vascular patterns and stromal features can also be seen.",
"   </p>",
"   <p>",
"    The sclerosing variant is characterized by dense fibrous stroma surrounding scattered small tubules, cords of cells, and individual cells with small nuclei and scant cytoplasm. Although there is scant published information, these tumors appear to be negative or weakly positive for cytokeratin, and are PLAP-negative. The pattern of staining for inhibin is unknown.",
"   </p>",
"   <p>",
"    Histologically, the differential diagnosis of testicular Sertoli cell tumors includes juvenile granulosa cell tumor, Leydig cell tumor or mixed Sertoli-Leydig cell tumor, and pure GCT or mixed germ cell-sex cord stromal tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/2,51\">",
"     2,51",
"    </a>",
"    ]. It has recently been suggested that many tumors originally classified as Sertoli cell tumor, NOS could be more accurately categorized as juvenile granulosa cell tumors, especially those found in preteen males (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immunohistochemistry can be helpful with difficult cases, as Sertoli cells are typically positive for cytokeratin and inhibin, and are negative for placental alkaline phosphatase (PLAP). Inhibin positively should be interpreted with caution if the differential diagnosis includes Leydig or granulosa cell tumors. In such circumstances, WT-1 positivity can be helpful as Leydig cell and granulosa cell tumors should not react with this marker. As mentioned above, SALL4 is negative in Sertoli cell tumors and therefore can be used to differentiate Sertoli cell tumors from GCTs, which are immunoreactive to SALL4 with high sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/13\">",
"     13",
"    </a>",
"    ]. As with Leydig cell tumors, the morphologic criteria for malignancy are not well established but increased size, vascular invasion, and increased numbers of mitotic figures are worrisome features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Granulosa cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;These rare neoplasms are morphologically similar to their ovarian counterparts, and like granulosa cell tumor in the ovary, are divided into adult and juvenile types. In the testis, the juvenile type is almost exclusively seen in children under the age of two years (see below). These tumors can be difficult to classify, since their histologic and immunophenotypic (eg, inhibin positive) features can overlap with other SCSTs. Granulosa cell tumors may be hormonally active or inactive.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adult type &mdash; The histologic features of the adult type of granulosa cell tumor are the same as with ovarian granulosa cell tumors. The cells have elongated, grooved nuclei, scant cytoplasm, and are arranged to form solid sheets and microfollicular structures (Call-Exner bodies). Although these tumors tend to be slow growing and associated with a favorable prognosis [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/59\">",
"       59",
"      </a>",
"      ], malignant behavior has occasionally been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/60\">",
"       60",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=see_link\">",
"       \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Juvenile type &mdash; The juvenile type of granulosa cell tumor is the most common (albeit unusual) testicular tumor of infancy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/61\">",
"       61",
"      </a>",
"      ], and is only rarely seen in adults. They appear to be uniformly benign. The cells of the juvenile type granulosa cell tumor lack the prominent grooving of the adult type, they tend to have somewhat more cytoplasm, and they do not show typical Call-Exner body formation. Rather, the cells are arranged in solid sheets, nests, or nodules and often form ectatic spaces filled with eosinophilic or basophilic material reminiscent of large follicles (",
"      <a class=\"graphic graphic_picture graphicRef60037 \" href=\"UTD.htm?36/20/37191\">",
"       picture 9",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mixed, other, and unclassified types",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with GCTs, mixed types of SCSTs can contain multiple components, each of which has features characteristic of the previously described types of SCST (eg, Sertoli-Leydig cell tumor). Examples of other types of mixed SCSTs in the testis resembling those seen in the ovary, such as fibroma-thecomas, have been reported but are very uncommon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=see_link\">",
"     \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\"",
"    </a>",
"    .) Occasionally, tumors have histologic aspects of one or more types of SCST, but without sufficient characteristic features to merit categorization as any recognized entity. These are termed SCSTs, unclassified type. A significant fraction of such tumors prove to be malignant, particularly in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     MIXED GCT AND SCST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadoblastomas consist of seminoma-like cells interspersed among cells resembling immature Sertoli cells that are arranged in a characteristic pattern. The Sertoli-like cells are arrayed in a palisading fashion around small collections of eosinophilic basement membrane material. Focal calcification is a prominent feature in most cases (",
"    <a class=\"graphic graphic_picture graphicRef78825 \" href=\"UTD.htm?26/45/27350\">",
"     picture 10",
"    </a>",
"    ). Occasionally, Leydig-like cells are also present. Each of the cell types has the expected immunohistochemical phenotype. It is believed that gonadoblastoma is a premalignant lesion with the potential for the development of germ cell tumors, especially seminoma, and gonadoblastoma can coexist with such a malignancy.",
"   </p>",
"   <p>",
"    Most gonadoblastomas arise within dysgenetic gonads. Mixed gonadal dysgenesis, cryptorchidism, and abnormalities of the external genitalia, such as ambiguous genitalia or hypospadias, are common. In some cases, female external",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    internal genitalia can be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/62\">",
"     62",
"    </a>",
"    ]. Although 80 percent of cases occur in phenotypic females, most have a 46 XY karyotype with the remainder exhibiting",
"    <span class=\"nowrap\">",
"     45,X/46,XY",
"    </span>",
"    mosaicism. Presentation is usually in childhood or adolescence in patients with male external genitalia.",
"   </p>",
"   <p>",
"    Phenotypic females may show some virilization, usually manifested by clitoral hypertrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/53\">",
"     53",
"    </a>",
"    ]. Endocrine manifestations are rare in phenotypic males, although gynecomastia may be present [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other, unclassified tumors consisting of a mixture of cells with the appearances of germ cells and sex cord-stromal cells are quite rare, and appear to be confined to adults. Further characterization has been hampered by their scarcity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     PARATESTICULAR TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of epithelial, mesothelial, and soft tissue tumors can develop in the rete testis and paratesticular tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Mesothelial lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mesothelial lesions involving the paratesticular region include mesothelial cysts, reactive mesothelial hyperplasia, adenomatoid tumors, benign cystic mesothelioma, well-differentiated papillary mesothelioma, and malignant mesothelioma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/63\">",
"     63",
"    </a>",
"    ]. The most common is the adenomatoid tumor, which is a benign mesothelial proliferation involving the testis, often in an infiltrative fashion. This infiltrative quality can lead to the erroneous assessment of this tumor as malignant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Epithelial tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare epithelial tumors of the paratesticular tissues include benign and malignant epithelial tumors of the rete testis, serous carcinoma, endometrioid adenocarcinoma, and mucinous cystadenocarcinoma tumors that are similar in appearance to those seen in women. Serous borderline tumors of the paratestis are histologically identical to their ovarian counterpart, and are thought to behave similarly [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17224?source=see_link&amp;anchor=H6#H6\">",
"     \"Epithelial ovarian cancer: Pathology\", section on 'Borderline tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brenner tumors (transitional cell carcinomas), papillary cystadenoma, desmoplastic small round cell tumor, lymphomas, leukemias, plasmacytomas, fibromas, vascular tumors, and sarcomas (eg, rhabdomyosarcoma) have all been rarely described in the testis or paratesticular tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/65\">",
"     65",
"    </a>",
"    ]. Metastatic deposits of carcinomas originating in a wide variety of organs, particularly the prostate and lung, have also been observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Testicular lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary testicular lymphoma is a unique and aggressive extranodal non-Hodgkin lymphoma with a high incidence of bilateral involvement, and a propensity for extranodal spread to the skin, subcutaneous tissue, bone marrow, central nervous system, and lung [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/66-71\">",
"     66-71",
"    </a>",
"    ]. In men over 60 years old, malignant lymphoma is the most common cause of a testicular mass (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50490 \" href=\"UTD.htm?22/1/22544\">",
"     image 1",
"    </a>",
"    ). Large cell diffuse B-cell types account for the majority of cases. In a recent series of 12 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/72\">",
"     72",
"    </a>",
"    ], seven patients presented at Ann Arbor stages",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    and five patients presented at Ann Arbor stages",
"    <span class=\"nowrap\">",
"     III/IV.",
"    </span>",
"    All patients reached complete remission after receiving doxorubicin-based chemotherapy. The rate of relapse was 8 percent and the progression-free survival at 10 years was 88 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/12/18634?source=see_link&amp;anchor=H1565171734#H1565171734\">",
"     \"Initial treatment of limited stage diffuse large B cell lymphoma\", section on 'Testicular'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Leukemia and plasmacytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 5 percent of boys with acute lymphoblastic leukemia, the testis is involved either at presentation or as a site of relapse following initial successful induction therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. Less commonly, adults with acute promyelocytic leukemia may have isolated testicular relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/75\">",
"     75",
"    </a>",
"    ]. Primary testicular plasmacytoma is an extremely rare tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16662?source=see_link\">",
"     \"Diagnosis and management of solitary extramedullary plasmacytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular neoplasms are the most common solid malignancy affecting men between the ages of 15 and 35 years, although they represent only 1 percent of all solid tumors in men [",
"    <a class=\"abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"     7",
"    </a>",
"    ]. The two main categories of testicular tumors are germ cell tumors (GCTs), which account for 95 percent of cases, and sex cord-stromal tumors, which comprise most of the remainder.",
"   </p>",
"   <p>",
"    These pathologic differences have critical implications for the natural history and subsequent management of patients with testicular tumors, as discussed here and in other topics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6789?source=see_link\">",
"     \"Testicular sex cord stromal tumors\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/1\">",
"      Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/2\">",
"      Ulbright TM. The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them. Adv Anat Pathol 2008; 15:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/3\">",
"      Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005; 18 Suppl 2:S61.",
"     </a>",
"    </li>",
"    <li>",
"     Testis. In: American Joint Committee on Cancer Staging Manual, 5th, Fleming ID, Cooper JS, Henson DE, et al (Eds), Lippincott-Raven Publishers, Philadelphia 1997. p.225.",
"    </li>",
"    <li>",
"     Setchell BP, Maddocks S, Brooks DE. Anatomy, vasculature, innervation, and fluids of the male reproductive tract. In: The Physiology of Reproduction, 2nd, Knobil E, Neill JD (Eds), Raven Press, New York 1994. p.1063.",
"    </li>",
"    <li>",
"     Weinstein MH. Lymphatic Drainage of the Testes. In: Atlas of the Urologic Clinics of North America: Testis Cancer, Rowland RG (Ed), W.B. Saunders Company, Philadelphia 1999. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/7\">",
"      Krag Jacobsen G, Barlebo H, Olsen J, et al. Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984; 23:239.",
"     </a>",
"    </li>",
"    <li>",
"     Ulbright TM, Amin MB, Young RH. Tumors of the Testis, Adenexa, Spermatic Cord, and Scrotum. In: Atlas of Tumor Pathology, 3rd, Rosai J, Sobin LH (Eds), Armed Forces Institute of Pathology, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/9\">",
"      Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol 2007; 31:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/10\">",
"      Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/11\">",
"      Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004; 28:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/12\">",
"      Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009; 115:2640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/13\">",
"      Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009; 33:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/14\">",
"      Wang F, Liu A, Peng Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol 2009; 33:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/15\">",
"      Liu A, Cheng L, Du J, et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol 2010; 34:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/16\">",
"      Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 2010; 34:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/17\">",
"      Reddy EK, Burke M, Giri S, et al. Testicular neoplasms: seminoma. J Natl Med Assoc 1990; 82:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/18\">",
"      Stein M, Dale J, Kuten A, Moshkowitz B. Anaplastic seminoma and spermatocytic seminoma--a retrospective analysis. S Afr J Surg 1993; 31:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/19\">",
"      Carri&egrave;re P, Baade P, Fritschi L. Population based incidence and age distribution of spermatocytic seminoma. J Urol 2007; 178:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/20\">",
"      Talerman A. Spermatocytic seminoma: clinicopathological study of 22 cases. Cancer 1980; 45:2169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/21\">",
"      Matoska J, Talerman A. Spermatocytic seminoma associated with rhabdomyosarcoma. Am J Clin Pathol 1990; 94:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/22\">",
"      Cummings OW, Ulbright TM, Eble JN, Roth LM. Spermatocytic seminoma: an immunohistochemical study. Hum Pathol 1994; 25:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/23\">",
"      Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments in histopathology of testicular germ cell tumors. Semin Urol 1988; 6:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/24\">",
"      Talerman A, Haije WG, Baggerman L. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. Cancer 1980; 46:380.",
"     </a>",
"    </li>",
"    <li>",
"     Brown NJ. Yolk-sac tumor (\"orchioblastoma\") and other testicular tumours of childhood. In: Pathology of the Testis, Pugh RC (Ed), Blackwell Scientific, Oxford 1976. p.356.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/26\">",
"      Pohl HG, Shukla AR, Metcalf PD, et al. Prepubertal testis tumors: actual prevalence rate of histological types. J Urol 2004; 172:2370.",
"     </a>",
"    </li>",
"    <li>",
"     Mostofi FK, Price EB Jr. Tumors of the male genital system. In: Atlas of Tumor Pathology, 2nd, Firminger HI (Ed), Armed Forces Institute of Pathology, Washington, DC 1973. p.53.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/28\">",
"      Brosman SA. Testicular tumors in prepubertal children. Urology 1979; 13:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/29\">",
"      Jones TD, Wang M, Sung MT, et al. Clonal origin of metastatic testicular teratomas. Clin Cancer Res 2006; 12:5377.",
"     </a>",
"    </li>",
"    <li>",
"     The male genital tract. In: Robbins Pathologic Basis of Disease, 6th, Cotran RS, Kumar V, Collins T (Eds), WB Saunders, Philadelphia 1999. p.1022.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/31\">",
"      Cheng L, Zhang S, MacLennan GT, et al. Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res 2006; 12:5668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/32\">",
"      Motzer RJ, Amsterdam A, Prieto V, et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 1998; 159:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/33\">",
"      Comiter CV, Kibel AS, Richie JP, et al. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 1998; 159:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/34\">",
"      Ganjoo KN, Foster RS, Michael H, et al. Germ cell tumor associated primitive neuroectodermal tumors. J Urol 2001; 165:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/35\">",
"      Donadio AC, Motzer RJ, Bajorin DF, et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol 2003; 21:4285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/36\">",
"      Ehrlich Y, Beck SD, Ulbright TM, et al. Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor. Ann Oncol 2010; 21:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/37\">",
"      G&ouml;bel U, Schneider DT, Calaminus G, et al. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 2000; 11:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/38\">",
"      Simmonds PD, Lee AH, Theaker JM, et al. Primary pure teratoma of the testis. J Urol 1996; 155:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/39\">",
"      Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer 1985; 56:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/40\">",
"      Skakkebaek NE, Berthelsen JG, M&uuml;ller J. Carcinoma-in-situ of the undescended testis. Urol Clin North Am 1982; 9:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/41\">",
"      Gabrilove JL, Nicolis GL, Mitty HA, Sohval AR. Feminizing interstitial cell tumor of the testis: personal observations and a review of the literature. Cancer 1975; 35:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/42\">",
"      Muir CS, Nectoux J. Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr 1979; :157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/43\">",
"      Atkin NB, Baker MC. Specific chromosome change, i(12p), in testicular tumours? Lancet 1982; 2:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/44\">",
"      van Echten J, Oosterhuis JW, Looijenga LH, et al. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer 1995; 14:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/45\">",
"      Bosl GJ, Ilson DH, Rodriguez E, et al. Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst 1994; 86:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/46\">",
"      Suijkerbuijk RF, Sinke RJ, Meloni AM, et al. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 1993; 70:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/47\">",
"      Roelofs H, Mostert MC, Pompe K, et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 2000; 157:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/48\">",
"      Rodriguez E, Houldsworth J, Reuter VE, et al. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer 1993; 8:230.",
"     </a>",
"    </li>",
"    <li>",
"     Ulbright TM, Amin MB, Young RH. Ulbright TM, Amin MB, Young RH. In: Atlas of Tumor Pathology, 3rd, Rosai J, Sobin LH (Eds), Armed Forces Institute of Pathology, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/50\">",
"      Cheville JC, Sebo TJ, Lager DJ, et al. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol 1998; 22:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/51\">",
"      Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 2005; 18 Suppl 2:S81.",
"     </a>",
"    </li>",
"    <li>",
"     Lawrence WD, Young RH, Scully RE. Sex cord - stromal tumors. In: Pathology of the Testis and its Adenexa - Contemporary Issues in Surgical Pathology, Talerman A, Roth LM (Eds), Churchill Livingstone, New York 1986. Vol 7.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/53\">",
"      Dilworth JP, Farrow GM, Oesterling JE. Non-germ cell tumors of testis. Urology 1991; 37:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/54\">",
"      Freeman DA. Steroid hormone-producing tumors in man. Endocr Rev 1986; 7:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/55\">",
"      Iczkowski KA, Bostwick DG, Roche PC, Cheville JC. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol 1998; 11:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/56\">",
"      McCluggage WG, Shanks JH, Whiteside C, et al. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. Am J Surg Pathol 1998; 22:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/57\">",
"      Ashley RA, McGee SM, Isotaolo PA, et al. Clinical and pathological features associated with the testicular tumor of the adrenogenital syndrome. J Urol 2007; 177:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/58\">",
"      Young RH, Koelliker DD, Scully RE. Sertoli cell tumors of the testis, not otherwise specified: a clinicopathologic analysis of 60 cases. Am J Surg Pathol 1998; 22:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/59\">",
"      Giannarini G, Mogorovich A, Menchini Fabris F, et al. Long-term followup after elective testis sparing surgery for Leydig cell tumors: a single center experience. J Urol 2007; 178:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/60\">",
"      Jimenez-Quintero LP, Ro JY, Zavala-Pompa A, et al. Granulosa cell tumor of the adult testis: a clinicopathologic study of seven cases and a review of the literature. Hum Pathol 1993; 24:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/61\">",
"      Garrett JE, Cartwright PC, Snow BW, Coffin CM. Cystic testicular lesions in the pediatric population. J Urol 2000; 163:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/62\">",
"      Gibbons B, Tan SY, Yu CC, et al. Risk of gonadoblastoma in female patients with Y chromosome abnormalities and dysgenetic gonads. J Paediatr Child Health 1999; 35:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/63\">",
"      Perez-Ordonez B, Srigley JR. Mesothelial lesions of the paratesticular region. Semin Diagn Pathol 2000; 17:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/64\">",
"      McClure RF, Keeney GL, Sebo TJ, Cheville JC. Serous borderline tumor of the paratestis: a report of seven cases. Am J Surg Pathol 2001; 25:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/65\">",
"      Henley JD, Ferry J, Ulbright TM. Miscellaneous rare paratesticular tumors. Semin Diagn Pathol 2000; 17:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/66\">",
"      Dalle JH, Mechinaud F, Michon J, et al. Testicular disease in childhood B-cell non-Hodgkin's lymphoma: the French Society of Pediatric Oncology experience. J Clin Oncol 2001; 19:2397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/67\">",
"      Vega F, Medeiros LJ, Abruzzo LV. Primary paratesticular lymphoma: a report of 2 cases and review of literature. Arch Pathol Lab Med 2001; 125:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/68\">",
"      Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000; 88:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/69\">",
"      Tondini C, Ferreri AJ, Siracusano L, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol 1999; 17:2854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/70\">",
"      Shahab N, Doll DC. Testicular lymphoma. Semin Oncol 1999; 26:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/71\">",
"      Seymour JF, Solomon B, Wolf MM, et al. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma 2001; 2:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/72\">",
"      Vural F, Cagirgan S, Saydam G, et al. Primary testicular lymphoma. J Natl Med Assoc 2007; 99:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/73\">",
"      Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience. Cancer 1998; 82:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/74\">",
"      Gutjahr P, Humpl T. Testicular lymphoblastic leukemia/lymphoma. World J Urol 1995; 13:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/75\">",
"      Forrest DL, Dalal BI, Naiman SC, et al. Testicular relapse of acute promyelocytic leukemia after allogeneic BMT. Bone Marrow Transplant 1997; 20:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/76\">",
"      Ferry JA, Young RH, Scully RE. Testicular and epididymal plasmacytoma: a report of 7 cases, including three that were the initial manifestation of plasma cell myeloma. Am J Surg Pathol 1997; 21:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/40/5770/abstract/77\">",
"      Fischer C, Terpe HJ, Weidner W, Schulz A. Primary plasmacytoma of the testis. Case report and review of the literature. Urol Int 1996; 56:263.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2949 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-217.16.9.173-E29AE5AA73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5770=[""].join("\n");
var outline_f5_40_5770=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TESTICULAR ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GERM CELL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Seminoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - \"Classic\" seminoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Anaplastic seminoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Spermatocytic seminoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Embryonal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Yolk sac tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Choriocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Teratoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Mature teratomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Immature teratomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Teratoma with malignant transformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mixed GCTs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Intratubular germ cell neoplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Metastatic GCTs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Extragonadal GCTs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Molecular markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SEX CORD-STROMAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Leydig cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sertoli cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Granulosa cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mixed, other, and unclassified types",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      MIXED GCT AND SCST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PARATESTICULAR TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Mesothelial lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Epithelial tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Testicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Leukemia and plasmacytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2949\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2949|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/1/22544\" title=\"diagnostic image 1\">",
"      Lymphoma testis ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2949|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/39/631\" title=\"picture 1\">",
"      Light microscopy seminoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/58/29607\" title=\"picture 2\">",
"      Light microscopy embryonal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/58/4008\" title=\"picture 3\">",
"      Light microscopy yolk sac tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/0/7175\" title=\"picture 4\">",
"      Light microscopy chorioCA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/56/23434\" title=\"picture 5\">",
"      Light microscopy teratoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/31/17910\" title=\"picture 6\">",
"      Light microscopy ITGCNU",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/0/16390\" title=\"picture 7\">",
"      Light microscopy Leydig tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/18/31015\" title=\"picture 8\">",
"      Light microscopy Sertoli tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/20/37191\" title=\"picture 9\">",
"      Light microscopy granulosa cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/45/27350\" title=\"picture 10\">",
"      Light microscopy gonadoblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2949|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/42/44715\" title=\"table 1\">",
"      Testicular tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/13/36061\" title=\"table 2\">",
"      TNM staging testicular CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16662?source=related_link\">",
"      Diagnosis and management of solitary extramedullary plasmacytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17224?source=related_link\">",
"      Epithelial ovarian cancer: Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10058?source=related_link\">",
"      Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/12/18634?source=related_link\">",
"      Initial treatment of limited stage diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=related_link\">",
"      Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=related_link\">",
"      Overview of the treatment of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/63/33782?source=related_link\">",
"      Radical inguinal orchiectomy for testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=related_link\">",
"      Retroperitoneal lymph node dissection in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34586?source=related_link\">",
"      Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/58/38822?source=related_link\">",
"      Serum tumor markers in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/27/42425?source=related_link\">",
"      Testicular intratubular germ cell neoplasia, unclassified (testicular carcinoma in situ, testicular intraepithelial neoplasia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6789?source=related_link\">",
"      Testicular sex cord stromal tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_40_5771="Likelihood ratios";
var content_f5_40_5771=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Likelihood ratios",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Likelihood ratio (LR)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Calculation",
"      </td>",
"      <td class=\"subtitle1\">",
"       Change in probability of success or failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       LR positive",
"      </td>",
"      <td rowspan=\"4\">",
"       Sensitivity/(1-specificity)",
"      </td>",
"      <td>",
"       LR = 1-2, none/minimal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR = 2-5, small",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR = 5-10, moderate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR &gt;10 = large",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       LR negative",
"      </td>",
"      <td rowspan=\"4\">",
"       (1-sensitivity)/specificity",
"      </td>",
"      <td>",
"       LR = 0.5-1, none/minimal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR = 0.3-0.5, small",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR = 0.1-0.3, moderate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LR &lt;0.1 = large",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LR: likelihood ratio.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5771=[""].join("\n");
var outline_f5_40_5771=null;
var title_f5_40_5772="USPSTF grade C recommendations";
var content_f5_40_5772=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78892&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78892&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult screening and prevention recommendations of USPSTF (September 2012) C recommendations (low priority)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Service",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for abdominal aortic aneurysm",
"       </td>",
"       <td>",
"        Never-smoking men ages 65 to 75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intensive behavioral dietary counseling",
"       </td>",
"       <td>",
"        Adults without risk factors for CVD and/or low readiness for change",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Lipid disorders",
"       </td>",
"       <td>",
"        Men ages 20 to 35 and women with no risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for breast cancer",
"       </td>",
"       <td>",
"        Women ages 40 to 49",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for colorectal cancer",
"       </td>",
"       <td>",
"        Men and women ages 76 to 85 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Sexually transmitted infections",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Screening for chlamydia",
"       </td>",
"       <td>",
"        Low-risk women; low-risk pregnant women and age 26+",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Other conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Behavioral counseling to promote a healthy diet and physcial activity",
"       </td>",
"       <td>",
"        Clinicians may choose to selectively consel patients (based upon risk for CVD, readiness for change, and resources to support change)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for osteoporosis",
"       </td>",
"       <td>",
"        Women younger than age 60; women 60 to 64 without risk factors",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    C: low priority, provide only for individual considerations.",
"    <div class=\"footnotes\">",
"     USPSTF: United States Preventive Services Task Force; CVD: cardiovascular disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5772=[""].join("\n");
var outline_f5_40_5772=null;
var title_f5_40_5773="Infectious causes of uveitis";
var content_f5_40_5773=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Representative infectious causes of uveitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Bacterial/spirochetal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Atypical mycobacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Brucellosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cat scratch disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leprosy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leptospirosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Propionibacterium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Whipple's disease",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Viral",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chikungunya",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cytomegalovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Epstein-Barr",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpes simplex",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpes zoster",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            HIV-1",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Human T cell leukemia virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mumps",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Parechovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rubella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rubeola",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vaccinia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            West Nile virus",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Fungal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspergillosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Blastomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Candidiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Coccidioidomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cryptococcosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Histoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumocystis jirovecii (PCP)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sporotrichosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1\">",
"            Parasitic (protozoan/helminthic)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acanthamoeba",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cystercercosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Onchocerciasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Toxocariasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Toxoplasmosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5773=[""].join("\n");
var outline_f5_40_5773=null;
var title_f5_40_5774="WHO MEC for gastrointestinal disorders";
var content_f5_40_5774=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    World Health Organization medical eligibility for contraceptive use: Gastrointestinal conditions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        COC",
"       </td>",
"       <td class=\"subtitle1\">",
"        CIC",
"       </td>",
"       <td class=\"subtitle1\">",
"        P/R",
"       </td>",
"       <td class=\"subtitle1\">",
"        POP",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         DMPA",
"        </p>",
"        <p>",
"         NET-EN",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         LNG/ETG",
"        </p>",
"        <p>",
"         Implants",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cu-IUD",
"       </td>",
"       <td class=\"subtitle1\">",
"        LNG-IUD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Gall-bladder disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"9\">",
"        Symptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Treated by cholecystectomy",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Medically treated",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Current",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asymptomatic",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        History of cholestasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pregnancy-related",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Past COC-related",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Viral hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute or flare",
"       </td>",
"       <td>",
"        <p>",
"         3/4 to initiate method",
"        </p>",
"        <p>",
"         2 to continue method",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         3 to initiate method",
"        </p>",
"        <p>",
"         2 to continue method",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         3/4 to initiate method",
"        </p>",
"        <p>",
"         2 to continue method",
"        </p>",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Carrier or chronic disease",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild (compensated)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Severe (decompensated)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Liver tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Benign hepatocellular adenoma",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Benign focal nodular hyperplasia",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malignant (hepatoma)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3/4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    1: A condition for which there is no restriction for the use of the contraceptive method.",
"    <br>",
"     2: A condition where the advantages of using the method generally outweigh the theoretical or proven risks.",
"     <br>",
"      3: A condition where the theoretical or proven risks usually outweigh the advantages of using the method.",
"      <br>",
"       4: A condition which represents an unacceptable health risk if the contraceptive method is used.",
"       <div class=\"footnotes\">",
"        COC: low-dose combined oral contraceptive; CIC: combined injectable contraceptives; P: combined patch; R: combined vaginal ring; POP: progestogen-only pill; DMPA: depot medroxyprogesterone acetate; NET-EN: norethisterone enantate; LNG: levonorgestrel; ETG: etonogestrel; ECP: emergency contraceptive pill; Cu-IUD: copper intrauterine device; LNG-IUD: levonorgestrel-releasing IUDs; E-IUD: copper-IUD for emergency contraception; BARR: barrier methods; FAB: fertility awareness-based methods; LAM: lactational amenorrhoea method; CI: coitus interruptus; STER: female and male sterilization.",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Medical Eligibility Criteria for Contraceptive Use - 3rd Ed. Available at: file://www.who.int/reproductive-health/publications/mec/summary.html. Copyright &copy; 2006 World Health Organization. Revised from: Medical Eligibility Criteria for Contraceptive Use, 2009 update. Available at: file://www.who.int/reproductive-health/publications/mec/.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5774=[""].join("\n");
var outline_f5_40_5774=null;
var title_f5_40_5775="Expanded disability status scale";
var content_f5_40_5775=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F57639&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F57639&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expanded disability status scale and functional systems",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Functional systems (FS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Pyramidal functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Abnormal signs without disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Minimal disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Mild or moderate paraparesis or hemiparesis; severe monoparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Paraplegia, hemiplegia, or marked quadriparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6. Quadriplegia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cerebellar functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Abnormal signs without disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Mild ataxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Moderate truncal or limb ataxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Severe ataxia, all limbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Unable to perform coordinated movements due to ataxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X. Is used throughout after each number when weakness (grade 3 or more on pyramidal) interferes with testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Brain stem functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Signs only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Moderate nystagmus or other mild disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Marked dysarthria or other marked disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Inability to swallow or speak",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Sensory functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Vibration or figure-writing decrease only, in one or two limbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Moderate decrease in touch or pain or position sense, and/or essentially lost vibration in one or two limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in three or four limbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6. Sensation essentially lost below the head",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Bowel and bladder functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Mild urinary hesitancy, urgency, or retention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Frequent urinary incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. In need of almost constant catheterization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Loss of bladder function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6. Loss of bowel and bladder function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Visual (or optic) functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Scotoma with visual acuity (corrected) better than 20/30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6. Grade 5 plus maximal visual acuity of better eye of 20/60 or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X. Is added to grades 0 to 6 for presence of temporal pallor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cerebral (or mental) functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Mood alteration only (Does not affect DSS score)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Mild decrease in mentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Moderate decrease in mentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Marked decrease in mentation (chronic brain syndrome-moderate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Dementia or chronic brain syndrome-severe or incompetent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Other functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0. None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Any other neurologic findings attributed to MS (specify)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        V. Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Expanded Disability Status Scale (EDSS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         0",
"        </strong>",
"        = Normal neurologic exam (all grade 0 in Functional Systems [FS]; Cerebral grade 1 acceptable)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         1.0",
"        </strong>",
"        = No disability, minimal signs in one FS (ie, grade 1 excluding Cerebral grade 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         1.5",
"        </strong>",
"        = No disability minimal signs in more than one FS (more than one grade 1 excluding Cerebral grade 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         2.0",
"        </strong>",
"        = Minimal disability in one FS (one FS grade 2, others 0 or 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         2.5",
"        </strong>",
"        = Minimal disability in two FS (two FS grade 2, others 0 or 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         3.0",
"        </strong>",
"        = Moderate disability in one FS (one FS grade 3, others 0 or l), or mild disability in three or four FS (three/four FS grade 2, others 0 or 1) though fully ambulatory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         3.5",
"        </strong>",
"        = Fully ambulatory but with moderate disability in one FS (one grade 3) and one or two FS grade 2; or two FS grade 3; or five FS grade 2 (others 0 or 1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         4.0",
"        </strong>",
"        = Fully ambulatory without aid, self-sufficient, up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or l), or combinations of lesser grades exceeding limits of previous steps. Able to walk without aid or rest some 500 meters.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         4.5",
"        </strong>",
"        = Fully ambulatory without aid, up and about much of the day, able to work a full day, may otherwise have some limitation of full activity or require minimal assistance; characterized by relatively severe disability, usually consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Able to walk without aid or rest for some 300 meters.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         5.0",
"        </strong>",
"        = Ambulatory without aid or rest for about 200 meters; disability severe enough to impair full daily activities (eg, to work full day without special provisions). (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding specifications for step 4.0.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         5.5",
"        </strong>",
"        = Ambulatory without aid or rest for about 100 meters; disability severe enough to preclude full daily activities. (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding those for step 4.0.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         6.0",
"        </strong>",
"        = Intermittent or unilateral constant assistance (cane, crutch, or brace) required to walk about 100 meters with or without resting. (Usual FS equivalents are combinations with more than two FS grade 3+.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         6.5",
"        </strong>",
"        = Constant bilateral assistance (canes, crutches, or braces) required to walk about 20 meters without resting. (Usual FS equivalents are combinations with more than two FS grade 3+.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         7.0",
"        </strong>",
"        = Unable to walk beyond about 5 meters even with aid, essentially restricted to wheelchair; wheels self in standard wheelchair and transfers alone; up and about in w/c some 12 hours a day. (Usual FS equivalents are combinations with more than one FS grade 4+; very rarely, pyramidal grade 5 alone.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         7.5",
"        </strong>",
"        = Unable to take more than a few steps; restricted to wheelchair; may need aid in transfer; wheels self but cannot carry on in standard wheelchair a full day; may require motorized wheelchair. (Usual FS equivalents are combinations with more than one FS grade 4+.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         8.0",
"        </strong>",
"        = Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed itself much of the day; retains many self-care functions; generally has effective use of arms. (Usual FS equivalents are combinations, generally grade 4+ in several systems.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         8.5",
"        </strong>",
"        = Essentially restricted to bed much of the day; has some effective use of arm(s); retains some self-care functions. (Usual FS equivalents are combinations, generally 4+ in several systems.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         9.0",
"        </strong>",
"        = Helpless bed patient; can communicate and eat. (Usual FS equivalents are combinations, mostly grade 4+.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         9.5",
"        </strong>",
"        = Totally helpless bed patient; unable to communicate effectively or eat/swallow. (Usual FS equivalents are combinations, almost all grade 4+.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         10",
"        </strong>",
"        = Death due to MS",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444. Copyright &copy; 1983 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_40_5775=[""].join("\n");
var outline_f5_40_5775=null;
